<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Natl Cancer Cent</journal-id><journal-id journal-id-type="iso-abbrev">J Natl Cancer Cent</journal-id><journal-id journal-id-type="pmc-domain-id">4608</journal-id><journal-id journal-id-type="pmc-domain">jncc</journal-id><journal-title-group><journal-title>Journal of the National Cancer Center</journal-title></journal-title-group><issn pub-type="ppub">2096-8663</issn><issn pub-type="epub">2667-0054</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12766194</article-id><article-id pub-id-type="pmcid-ver">PMC12766194.1</article-id><article-id pub-id-type="pmcaid">12766194</article-id><article-id pub-id-type="pmcaiid">12766194</article-id><article-id pub-id-type="pmid">41497262</article-id><article-id pub-id-type="doi">10.1016/j.jncc.2025.05.006</article-id><article-id pub-id-type="pii">S2667-0054(25)00092-4</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Full Length Article</subject></subj-group></article-categories><title-group><article-title>Do ethnic disparities exist in disease burden and healthcare utilization of male breast cancer? A 9-year cohort study of 9.08 million adults in China</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name name-style="western"><surname>Chen</surname><given-names initials="J">Jieying</given-names></name><xref rid="aff0001" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">&#8224;</xref></contrib><contrib contrib-type="author" id="au0002"><name name-style="western"><surname>Qiao</surname><given-names initials="L">Liying</given-names></name><xref rid="aff0002" ref-type="aff">2</xref><xref rid="fn1" ref-type="fn">&#8224;</xref></contrib><contrib contrib-type="author" id="au0003"><name name-style="western"><surname>Yan</surname><given-names initials="Y">Ying</given-names></name><xref rid="aff0003" ref-type="aff">3</xref><xref rid="fn1" ref-type="fn">&#8224;</xref></contrib><contrib contrib-type="author" id="au0004"><name name-style="western"><surname>Qi</surname><given-names initials="M">Meng</given-names></name><xref rid="aff0004" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yunjing</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0006"><name name-style="western"><surname>Kang</surname><given-names initials="W">Weiwei</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au0007"><name name-style="western"><surname>Zhou</surname><given-names initials="H">Huziwei</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0008"><name name-style="western"><surname>Yu</surname><given-names initials="Y">Yuelin</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0009"><name name-style="western"><surname>Ke</surname><given-names initials="Y">Yalei</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Jiang</surname><given-names initials="Y">Yuling</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0011"><name name-style="western"><surname>Rao</surname><given-names initials="Y">Yingting</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0012"><name name-style="western"><surname>Xu</surname><given-names initials="L">Lu</given-names></name><xref rid="aff0006" ref-type="aff">6</xref></contrib><contrib contrib-type="author" id="au0013"><name name-style="western"><surname>He</surname><given-names initials="G">Guohua</given-names></name><xref rid="aff0007" ref-type="aff">7</xref></contrib><contrib contrib-type="author" id="au0014"><name name-style="western"><surname>Ren</surname><given-names initials="J">Jing</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au0015"><name name-style="western"><surname>Yan</surname><given-names initials="X">Xue</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au0016"><name name-style="western"><surname>Deng</surname><given-names initials="S">Siwei</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0017"><name name-style="western"><surname>Yang</surname><given-names initials="X">Xinyu</given-names></name><xref rid="aff0008" ref-type="aff">8</xref></contrib><contrib contrib-type="author" id="au0018"><name name-style="western"><surname>Song</surname><given-names initials="Y">Yutong</given-names></name><xref rid="aff0008" ref-type="aff">8</xref></contrib><contrib contrib-type="author" id="au0019"><name name-style="western"><surname>Yang</surname><given-names initials="Y">Yingzi</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0020"><name name-style="western"><surname>Wen</surname><given-names initials="Q">Qiaorui</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0021"><name name-style="western"><surname>Han</surname><given-names initials="J">Jing</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au0022"><name name-style="western"><surname>Wu</surname><given-names initials="Y">Yiwei</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au0023"><name name-style="western"><surname>Liu</surname><given-names initials="G">Guozhen</given-names></name><xref rid="aff0009" ref-type="aff">9</xref></contrib><contrib contrib-type="author" id="au0024"><name name-style="western"><surname>Wang</surname><given-names initials="M">Mingyuan</given-names></name><xref rid="aff0010" ref-type="aff">10</xref></contrib><contrib contrib-type="author" id="au0025"><name name-style="western"><surname>Zhang</surname><given-names initials="X">Xiaoyu</given-names></name><xref rid="aff0008" ref-type="aff">8</xref></contrib><contrib contrib-type="author" id="au0026"><name name-style="western"><surname>Xi</surname><given-names initials="Y">Yunfeng</given-names></name><email>xiyunfeng210@163.com</email><xref rid="aff0002" ref-type="aff">2</xref><xref rid="cor0001" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author" id="au0027"><name name-style="western"><surname>Wang</surname><given-names initials="S">Shengfeng</given-names></name><email>shengfeng1984@126.com</email><xref rid="aff0005" ref-type="aff">5</xref><xref rid="aff0011" ref-type="aff">11</xref><xref rid="cor0001" ref-type="corresp">&#8270;</xref></contrib><aff id="aff0001"><label>1</label>School of Health Humanities, Peking University, Beijing, China</aff><aff id="aff0002"><label>2</label>Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine)</aff><aff id="aff0003"><label>3</label>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital &amp; Institute, Beijing, China</aff><aff id="aff0004"><label>4</label>Breast Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China</aff><aff id="aff0005"><label>5</label>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China</aff><aff id="aff0006"><label>6</label>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China</aff><aff id="aff0007"><label>7</label>The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China</aff><aff id="aff0008"><label>8</label>School of Public Health, Peking University, Beijing, China</aff><aff id="aff0009"><label>9</label>China Unicom Digital Intelligence Medical Technology Co., Ltd, Beijing, China</aff><aff id="aff0010"><label>10</label>Peking University Health Information Technology Co., Ltd, Beijing, China</aff><aff id="aff0011"><label>11</label>Key Laboratory of Epidemiology of Major Diseases (Ministry of Education/Beijing), Peking University, Beijing, China</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#8270;</label>Corresponding authors. <email>xiyunfeng210@163.com</email><email>shengfeng1984@126.com</email></corresp><fn id="fn1"><label>&#8224;</label><p id="notep0001">These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="collection"><month>12</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2025</year></pub-date><volume>5</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">503959</issue-id><fpage>577</fpage><lpage>585</lpage><history><date date-type="received"><day>21</day><month>8</month><year>2024</year></date><date date-type="rev-recd"><day>30</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>6</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>06</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-01-07 09:25:13.140"><day>07</day><month>01</month><year>2026</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 Chinese National Cancer Center. Published by Elsevier B.V.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder/><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0001"><sec><title>Background</title><p>As a rare disease, male breast cancer (MBC) is of increasing concern in China. Whether health inequalities of disease burden and healthcare utilization exist by ethnicity in male breast cancer remains unclear. We aim to measure disease burden and healthcare utilization by ethnicity among male breast cancer patients in China.</p></sec><sec><title>Methods</title><p>A retrospective cohort study was established during 2012&#8211;2021 based on the Inner Mongolia Regional Health Information Platform. Disease burden, including incidence, 5-year prevalence, mortality, survival rate, and medical cost were analyzed.</p></sec><sec><title>Results</title><p>Among 630 participants (mean [SD] age, 59.4 [13.1] years), age-standardized rates of incidence were 1.2 (95% CI: 0.4&#8211;2.1) per 100, 000. All-cause mortality was 50.8 per 1000 person-years (95% CI: 42.4&#8211;60.4). Regarding ethnicity, Mongolian had a higher age-standardized 5-year prevalence rate than Han (3.2[95% CI: 2.5&#8211;4.0] vs 2.3[95% CI: 1.7&#8211;3.0], <italic toggle="yes">P</italic>=0.016), but no significant differences existed in incidence rates, survival rates, and risk of all-cause and breast cancer-specific mortality. Meanwhile, few significant disparities in healthcare utilization between Han and Mongolian were observed.</p></sec><sec><title>Conclusions</title><p>This study revealed a moderate disease burden and relatively lower healthcare utilization for male breast cancer in Inner Mongolia, China. No significant ethnic disparities existed in disease burden and healthcare utilization. However, increased attention to male breast cancer is warranted due to the crucial influence of economic factors on potential ethnic disparities.</p></sec></abstract><kwd-group id="keys0001"><title>Keywords</title><kwd>Male breast cancer</kwd><kwd>Ethnic disparities</kwd><kwd>Rare disease</kwd><kwd>Disease burden</kwd><kwd>Healthcare utilization</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec0001"><label>1</label><title>Background</title><p id="para0006">Male breast cancer (MBC) is a rare disease accounting for approximately 1 % of all breast cancer.<xref rid="bib0001" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib0002" ref-type="bibr"><sup>2</sup></xref> Breast cancer has been traditionally regarded as a female-specific disease, leading to the lack of awareness of MBC. However, the disease burden of MBC has kept growing over the past decades.<xref rid="bib0003" ref-type="bibr"><sup>3</sup></xref> Due to the deficiency of randomized controlled trials of MBC, treatment regimes were usually extrapolated from guidelines for female breast cancer (FBC) nowadays,<xref rid="bib0004" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib0005" ref-type="bibr"><sup>5</sup></xref> but substantial disparities have been observed between MBC and FBC.<xref rid="bib0006" ref-type="bibr"><sup>6</sup></xref> Therefore, treatment regimens for females might not be fully applicable in males, leading to poor adherence and worse prognosis.<xref rid="bib0007" ref-type="bibr"><sup>7</sup></xref> However, the prognostic outcomes of MBC compared with FBC in Asians remain inconsistent across studies. In Republic of Korea, the 5-year overall survival rate was lower for MBC than for FBC (76.2 % vs 88.9 %),<xref rid="bib0008" ref-type="bibr"><sup>8</sup></xref> but a study in Hong Kong of China suggested that MBC did not show lower survival until 10 years later.<xref rid="bib0009" ref-type="bibr"><sup>9</sup></xref> Previous studies in Chinese mainland were not convincing enough because of the small sample sizes (ranging from 24 to 106 male patients).<xref rid="bib0010" ref-type="bibr">10</xref>, <xref rid="bib0011" ref-type="bibr">11</xref>, <xref rid="bib0012" ref-type="bibr">12</xref> Furthermore, healthcare utilization for MBC has not been well studied so far, with only one study conducted globally.<xref rid="bib0013" ref-type="bibr"><sup>13</sup></xref> Therefore, it is crucial to explore the current situation of MBC and provide more evidence for formulating policies and guidelines for this rare disease.</p><p id="para0007">Notably, race/ethnicity plays a part in the disparities in the disease burden of breast cancer.<xref rid="bib0014" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="bib0015" ref-type="bibr"><sup>15</sup></xref> Most studies on racial/ethnic differences have focused on African Americans for both MBC and FBC, whereas Asians were included in only a few studies and often classified into &#8220;others&#8221;.<xref rid="bib0016" ref-type="bibr">16</xref>, <xref rid="bib0017" ref-type="bibr">17</xref>, <xref rid="bib0018" ref-type="bibr">18</xref> In terms of MBC, a few studies reported the racial/ethnic disparities in incidence in the general population, of which Asian was combined with Pacific Islanders, Hispanic, or others.<xref rid="bib0018" ref-type="bibr">18</xref>, <xref rid="bib0019" ref-type="bibr">19</xref>, <xref rid="bib0020" ref-type="bibr">20</xref>, <xref rid="bib0021" ref-type="bibr">21</xref>, <xref rid="bib0022" ref-type="bibr">22</xref> Significant disparities in disease burden of FBC have been observed within Asian countries at the national level,<xref rid="bib0023" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bib0024" ref-type="bibr"><sup>24</sup></xref> but the situation of MBC cannot be extrapolated due to the prominent differences between FBC and MBC. The situation within Asian ethnic groups remains unclear as well.</p><p id="para0008">In a word, no studies of ethnic disparities have been conducted in China, which contributed the most breast cancer patients (18.4 % in 2020) in the world.<xref rid="bib0025" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="bib0026" ref-type="bibr"><sup>26</sup></xref> As the third largest provincial-level administrative division in China, Inner Mongolia has a population of 4.25 million Mongolian, accounting for over 70 % of the Mongolian population in China and 50 % in the world. Inner Mongolia Regional Health Information Platform (IMRHIP) aims to address cancer health disparities across ethnicities by collecting and administrating healthcare information of residents in Inner Mongolia.<xref rid="bib0026" ref-type="bibr"><sup>26</sup></xref> In this study, we aimed to outline ethnic disparities of disease burden of male breast cancer based on IMRHIP to provide further understanding of the rare disease.</p></sec><sec id="sec0002"><label>2</label><title>Materials and methods</title><sec id="sec0003"><label>2.1</label><title>Data sources</title><p id="para0009">This retrospective cohort study used data from the IMRHIP. The IMRHIP integrated and collected data from National Basic Medical Insurance (NBMI), National Cancer Registry (NCR), Inpatient Medical Record Homepage Data, and Cause-of-death Reporting System (CDRS) since 2012 with provincial coverage of 95 % by 2020.<xref rid="bib0026" ref-type="bibr">26</xref>, <xref rid="bib0027" ref-type="bibr">27</xref>, <xref rid="bib0028" ref-type="bibr">28</xref> The configuration and working flow of the platform were shown in the Supplementary methods and Supplementary Fig. 1. The NBMI included the Urban Employee Basic Medical Insurance database covering urban employees and the Urban Resident Basic Medical Insurance database covering unemployed urban and rural residents. Socioeconomic information, including ethnicity and residence, records of inpatient and outpatient services, diagnostic information, and cost information were obtained in NBMI. The information was registered when patients purchase health insurance and generated when they use the insurance account. The NCR collected and managed tumor incidence, death, and survival data, providing variables such as date of onset, disease diagnoses, tumor characteristics, etc. Inpatient medical record homepage data was derived from electronic medical records, including demographic information, hospitalization information, diagnosis and treatment information, etc. The CDRS gathered data from the National Health Commission, national disease surveillance sites, and provinces and cities through an information management system, where we obtained information on the direct cause of death, date of death, etc. Patient information, including the abovementioned variables, was recorded and linked by encrypted ID numbers among databases. All records were deidentified to protect patients&#8217; privacy. The information about the Surveillance Cohort of All Cancers Species has been shared on the China Cohort Consortium (No. CCC2023050801). Informed consent from participants was approved for exemption, approved by the medical ethics committee (NMCDCIRB2021001).</p></sec><sec id="sec0004"><label>2.2</label><title>Study population</title><p id="para0010">Patients diagnosed with breast cancer between January 1, 2012 and March 9, 2021 in the NBMI were identified by diagnostic text and the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) code of breast cancer (C50). First, the dictionary of breast cancer diagnostic names was created using records in the NBMI. Next, the diagnostic information in other sub-databases was used to match and double-check the results. Natural language processing was applied to standardize the diagnostic text and code, with two researchers conducting this process independently and a third one double-checking. More methodological details were shown in the Supplementary methods, Supplementary Table 1, and Supplementary Fig. 2. Patients without ID numbers (<italic toggle="yes">n</italic> = 10) and female patients (<italic toggle="yes">n</italic> = 34 955) were excluded. The patients were followed up until death or the end of the study, whichever came first.</p></sec><sec id="sec0005"><label>2.3</label><title>Measurements</title><p id="para0011">The tumor stage was defined into early (stage 0&#8211;&#8546;), advanced (stage &#8547;), and unknown according to whether a breast cancer surgery can be operated on the patient. Age at diagnosis was categorized into three groups: 18&#8211;40, 41&#8211;60, and&#8805;61 years because the association between age and outcomes were non-linear. Charlson comorbidity index (CCI) score was calculated and categorized as 0, 1, 2, and &#8805;3,<xref rid="bib0029" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="bib0030" ref-type="bibr"><sup>30</sup></xref> in which the comorbidities diagnosed both before and after the diagnosis of breast cancer were included. Data on alcohol consumption and smoking rates were obtained from the 2018 Adult Chronic Disease and Nutrition Monitoring Survey in Inner Mongolia.<xref rid="bib0026" ref-type="bibr"><sup>26</sup></xref> Gross domestic product (GDP) per capita in 2020,<xref rid="bib0031" ref-type="bibr"><sup>31</sup></xref> alcohol consumption rate, and smoking rate were stratified into two levels (high/low) by prefecture-level divisions (including leagues and cities) according to the median. Treatments for breast cancer included surgery, chemotherapy, endocrine therapy, targeted therapy, and radiotherapy.<xref rid="bib0032" ref-type="bibr"><sup>32</sup></xref></p></sec><sec id="sec0006"><label>2.4</label><title>Statistical analysis</title><p id="para0012">Our analyses included three parts. First, incidence and 5-year prevalence were calculated. For incidence rates, a window of two years (2012 and 2013) was set to exclude prevalent cases when calculating the incidence rate for each of the 7 years from 2014 to 2020.<xref rid="bib0027" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib0033" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib0034" ref-type="bibr"><sup>34</sup></xref> For instance, if one&#8217;s diagnosis of breast cancer appeared in 2014 (or later) for the first time, he was considered to be a new case of that year. The numerator of incidence was the number of new cases of breast cancer each year. Sensitivity analysis using a 3-year washout period and a 4-year washout period was performed to test the robustness of this identifying strategy. For 5-year prevalence rates, the numerator was the number of patients alive with breast cancer diagnoses during the past 5 years for each year from 2017 to 2021.<xref rid="bib0027" ref-type="bibr"><sup>27</sup></xref> The denominator for incidence and 5-year prevalence was the total number of male adult residents each year in NBMI. For example, for the rate of 2017, the numerator contained surviving patients whose incidence year was 2012, 2013, 2014, 2015, or 2016, and the denominator was the male adult residents in 2017 in NBMI.</p><p id="para0013">The average estimates in the subgroups were calculated by combining the estimates each year using a random effects meta-analysis<xref rid="bib0035" ref-type="bibr"><sup>35</sup></xref> based on the Clopper-Pearson method.<xref rid="bib0036" ref-type="bibr"><sup>36</sup></xref> The 95 % confidence intervals (CIs) were estimated by the Poisson distribution. Subgroup analyses were conducted according to the GDP level of the residence. Age-standardized rates (ASR) were determined using the World Health Organization world standardized rates, 2000 to 2025.<xref rid="bib0037" ref-type="bibr"><sup>37</sup></xref> To make the ASR comparable, sensitivity analysis was demonstrated to calculate the ASR of incidence using different world standard population.<xref rid="bib0038" ref-type="bibr"><sup>38</sup></xref><sup>,</sup><xref rid="bib0039" ref-type="bibr"><sup>39</sup></xref></p><p id="para0014">Second, health utilization, including overall services and specifically for breast cancer of inpatient and outpatient, was measured by costs per capita, annually per capita, and per episode (exchange rate: US $1.00 =&#165;6.47 yuan on July 15, 2020). The annual cost was equal to the total cost divided by the follow-up years (years after diagnosis). The cost of each kind of treatment was calculated. The number of inpatient and outpatient visits overall and specifically for breast cancer were also calculated.</p><p id="para0015">Third, 5-, 3-, 2-, and 1-year survival rates were calculated using the Kaplan-Meier method.<xref rid="bib0040" ref-type="bibr">40</xref>, <xref rid="bib0041" ref-type="bibr">41</xref>, <xref rid="bib0042" ref-type="bibr">42</xref> Log-rank test and z-test were used to compare ethnic disparities in survival rates.<xref rid="bib0043" ref-type="bibr"><sup>43</sup></xref> A sensitivity analysis was conducted to offer unbiased estimations, calculating the rates by cohort analysis.<xref rid="bib0040" ref-type="bibr">40</xref>, <xref rid="bib0041" ref-type="bibr">41</xref>, <xref rid="bib0042" ref-type="bibr">42</xref> In survival analyses, since the proportional hazard assumption was not satisfied by stage, a stratified Cox model was performed for all-cause mortality. The Fine and Gray competing risk model and Cause-specific hazard model were performed for breast cancer-specific mortality to estimate hazard ratios (HR) and 95 % CI. Age at diagnosis, GDP level of residence, alcohol consumption rate, smoking rate, CCI, all treatments, and stage were adjusted.</p><p id="para0016">Mean&#177;standard error (SD), median (interquartile range, IQR), and frequency (proportion) were presented for normal continuous variables, non-normal continuous variables, and categorical variables, respectively. &#967;<sup>2</sup> test, t-test, and Kruskal-Wallis test were performed to compare the difference between variables of interest. All statistical analyses were performed with R version 4.1.3, and a two-sided <italic toggle="yes">P</italic> &lt; 0.05 was considered statistically significant. Data were analyzed and reported following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline<xref rid="bib0044" ref-type="bibr"><sup>44</sup></xref> and the Strengthening The Reporting Of Cohort Studies in Surgery (STROCSS).<xref rid="bib0045" ref-type="bibr"><sup>45</sup></xref></p></sec></sec><sec id="sec0007"><label>3</label><title>Results</title><sec id="sec0008"><label>3.1</label><title>Demographic characteristics</title><p id="para0017">In a total of 9.08 million participants (Supplementary Table 3), 630 male breast cancer patients were identified, contributing to 2539.4 person-years. Among them, 62 (9.8%) were Mongolian, and 521(82.7%) were Han. Han in MBC were more likely to be diagnosed 5 years older (60.0 years vs 55.4 years, <italic toggle="yes">P</italic>=0.016) and more distributed in the residence with high GDP level (56.% vs 37.1%, <italic toggle="yes">P</italic>=0.006). No significant results were found in follow-up years, stage, CCI score, smoking rate, and alcohol consumption rate (<xref rid="tbl0001" ref-type="table">Table 1</xref>).<table-wrap position="float" id="tbl0001" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics of male breast cancer patients during 2012&#8211;2021 in Inner Mongolia, grouped by ethnicity.<xref rid="tb1fn1" ref-type="table-fn">a</xref></p></caption><alt-text id="alt0003">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top" colspan="1" rowspan="1"/><th valign="top" colspan="1" rowspan="1">Overall<xref rid="tb1fn1" ref-type="table-fn">a</xref></th><th valign="top" colspan="1" rowspan="1">Han</th><th valign="top" colspan="1" rowspan="1">Mongolian</th><th align="left" valign="top" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td valign="top" colspan="1" rowspan="1">Total, n (%)</td><td valign="top" colspan="1" rowspan="1">630 (1.8)</td><td valign="top" colspan="1" rowspan="1">521 (82.7)</td><td valign="top" colspan="1" rowspan="1">62 (9.8)</td><td align="left" valign="top" colspan="1" rowspan="1">&#8211;</td></tr><tr><td valign="top" colspan="1" rowspan="1">Age at diagnosis, mean &#177; SD, years</td><td valign="top" colspan="1" rowspan="1">59.4 &#177; 13.1</td><td valign="top" colspan="1" rowspan="1">60.0 &#177; 13.0</td><td valign="top" colspan="1" rowspan="1">55.4 &#177; 14.1</td><td align="left" valign="top" colspan="1" rowspan="1">0.016</td></tr><tr><td valign="top" colspan="1" rowspan="1">Follow-up, median (IQR), years</td><td valign="top" colspan="1" rowspan="1">3.7 (2.7&#8211;6.8)</td><td valign="top" colspan="1" rowspan="1">3.6 (1.5&#8211;7.0)</td><td valign="top" colspan="1" rowspan="1">3.6 (1.5&#8211;5.5)</td><td align="left" valign="top" colspan="1" rowspan="1">0.653</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Clinical stage, n (%)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Early: 0-&#8546;</td><td valign="top" colspan="1" rowspan="1">276 (43.8)</td><td valign="top" colspan="1" rowspan="1">230 (44.2)</td><td valign="top" colspan="1" rowspan="1">26 (41.9)</td><td rowspan="3" align="left" valign="top" colspan="1">0.172</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Advanced: &#8547;</td><td valign="top" colspan="1" rowspan="1">192 (30.5)</td><td valign="top" colspan="1" rowspan="1">147 (28.2)</td><td valign="top" colspan="1" rowspan="1">26 (41.9)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Unknown</td><td valign="top" colspan="1" rowspan="1">162 (25.7)</td><td valign="top" colspan="1" rowspan="1">144 (27.6)</td><td valign="top" colspan="1" rowspan="1">10 (16.1)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Charlson comorbidity index score<xref rid="tb1fn2" ref-type="table-fn">b</xref>, n (%)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;0</td><td valign="top" colspan="1" rowspan="1">253 (40.2)</td><td valign="top" colspan="1" rowspan="1">218 (41.8)</td><td valign="top" colspan="1" rowspan="1">21 (33.9)</td><td rowspan="4" align="left" valign="top" colspan="1">0.686</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;1</td><td valign="top" colspan="1" rowspan="1">82 (13.0)</td><td valign="top" colspan="1" rowspan="1">66 (12.7)</td><td valign="top" colspan="1" rowspan="1">9 (14.5)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;2</td><td valign="top" colspan="1" rowspan="1">59 (9.4)</td><td valign="top" colspan="1" rowspan="1">49 (9.4)</td><td valign="top" colspan="1" rowspan="1">7 (11.3)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;&#8805;3</td><td valign="top" colspan="1" rowspan="1">236 (37.5)</td><td valign="top" colspan="1" rowspan="1">188 (36.1)</td><td valign="top" colspan="1" rowspan="1">25 (40.3)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">GDP level of residence<xref rid="tb1fn3" ref-type="table-fn">c</xref>, n (%)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Low</td><td valign="top" colspan="1" rowspan="1">295 (47.0)</td><td valign="top" colspan="1" rowspan="1">227 (43.6)</td><td valign="top" colspan="1" rowspan="1">39 (62.9)</td><td rowspan="2" align="left" valign="top" colspan="1">0.006</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;High</td><td valign="top" colspan="1" rowspan="1">333 (53.0)</td><td valign="top" colspan="1" rowspan="1">292 (56.1)</td><td valign="top" colspan="1" rowspan="1">23 (37.1)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">GDP level of residence stratified by quartiles<xref rid="tb1fn4" ref-type="table-fn">d</xref>, n (%)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Low</td><td valign="top" colspan="1" rowspan="1">88 (14.0)</td><td valign="top" colspan="1" rowspan="1">144 (27.8)</td><td valign="top" colspan="1" rowspan="1">12 (19.4)</td><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Middle-low</td><td valign="top" colspan="1" rowspan="1">245 (39.0)</td><td valign="top" colspan="1" rowspan="1">83 (16.0)</td><td valign="top" colspan="1" rowspan="1">27 (43.6)</td><td rowspan="2" align="left" valign="top" colspan="1">&lt;0.001</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Middle-high</td><td valign="top" colspan="1" rowspan="1">135 (21.5)</td><td valign="top" colspan="1" rowspan="1">207 (39.9)</td><td valign="top" colspan="1" rowspan="1">22 (35.5)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;High</td><td valign="top" colspan="1" rowspan="1">160 (25.5)</td><td valign="top" colspan="1" rowspan="1">85 (16.4)</td><td valign="top" colspan="1" rowspan="1">1 (1.6)</td><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Smoking rate<xref rid="tb1fn5" ref-type="table-fn">e</xref>, n (%)</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Low</td><td valign="top" colspan="1" rowspan="1">354 (60.9)</td><td valign="top" colspan="1" rowspan="1">315 (60.7)</td><td valign="top" colspan="1" rowspan="1">39 (62.9)</td><td rowspan="2" align="left" valign="top" colspan="1">0.736</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;High</td><td valign="top" colspan="1" rowspan="1">227 (39.1)</td><td valign="top" colspan="1" rowspan="1">204 (39.3)</td><td valign="top" colspan="1" rowspan="1">23 (37.1)</td></tr><tr><td valign="top" colspan="1" rowspan="1">Alcohol consumption rate<xref rid="tb1fn6" ref-type="table-fn">f</xref>, n (%)</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Low</td><td valign="top" colspan="1" rowspan="1">360 (62.0)</td><td valign="top" colspan="1" rowspan="1">326 (62.8)</td><td valign="top" colspan="1" rowspan="1">34 (54.8)</td><td rowspan="2" align="left" valign="top" colspan="1">0.222</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;High</td><td valign="top" colspan="1" rowspan="1">221 (38.0)</td><td valign="top" colspan="1" rowspan="1">193 (37.2)</td><td valign="top" colspan="1" rowspan="1">28 (45.2)</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: GDP, gross domestic product; IQR, interquartile range; SD, standard deviation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn1"><label>a</label><p id="notep0003">There were missing data for GDP level of residence (2 cases, both cases were Han individuals). No significant ethnic disparities in the completeness of data were found. 47 (7.5%) patients categorized into the ethnic group of &#8220;others&#8221; (all non-Han and non-Mongolian ethnicities) were included in &#8220;Overall.&#8221;</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn2"><label>b</label><p id="notep0004">Charlson comorbidity index score was calculated and categorized as 0, 1, 2, and &#8805;3.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn3"><label>c</label><p id="notep0005">GDP level of residence was stratified into two levels (high/low) by prefecture-level divisions according to the median of GDP per capita in 2020 (&#165;66,377.0 = $10,259.2). High: &#8805;&#165;66,377.0; Low: &lt;&#165;66,377.0.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn4"><label>d</label><p id="notep0006">Quartile groups (Low, Middle-low, Middle-high, High) were defined by GDP per capita distribution quartiles of prefecture-level divisions.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn5"><label>e</label><p id="notep0007">Smoking rate was stratified into two levels (high/low) by prefecture-level divisions according to the median (10.1%). High: &#8805;10.1 %; Low: &lt;10.1 %.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn6"><label>f</label><p id="notep0008">Alcohol consumption rate was stratified into two levels (high/low) by prefecture-level divisions according to the median (10.7%). High: &#8805;10.7 %; Low: &lt;10.7 %.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec0009"><label>3.2</label><title>Incidence and prevalence</title><p id="para0018">The ASR of incidence for MBC during 2014&#8211;2020 was 1.2 (95% CI: 0.4&#8211;2.1) per 100,000; when stratified by ethnicity, the rates were 0.7 (95% CI: 0&#8211;1.5) per 100,000 in Han, 0.9 (95% CI: 0.1&#8211;1.7) per 100,000 in Mongolian, and 2.2 (95% CI: 0&#8211;4.6) per 100,000 in other ethnic groups. The difference between Han and Mongolian was not significant (<italic toggle="yes">P</italic>=0.424) (Supplementary Table 4). The results of the sensitivity analysis of incidence rates calculation using different washout periods were displayed in Supplementary Table 2, showing conservative estimation. The ASRs of incidence using other world standard populations were shown in Supplementary Table 5 and Supplementary Table 6, which displayed consistent estimation. The combined crude incidence rate during 2014&#8211;2020 was 1.5 (95% CI: 0.8&#8211;2.1) per 100,000. The ASR of prevalence for MBC during 2017&#8211;2021 was 4.2 (95% CI: 3.0&#8211;5.5) per 100,000, and Mongolian&#8217;s was significantly higher than Han&#8217;s (3.2[2.5&#8211;4.0] vs 2.3[1.7&#8211;3.0], <italic toggle="yes">P</italic>= 0.016).</p><p id="para0019">The crude prevalence during 2017&#8211;2021 was 5.6 (95% CI: 4.2&#8211;6.9). The 5-year prevalence in 2021 was 3.0 (95% CI: 2.1&#8211;3.9) per 100 000 in MBC, of which Han was 3.1 (95% CI: 2.7&#8211;3.5) and Mongolian was 3.6 (95% CI: 2.5&#8211;5.0) (Supplementary Table 7). The age-specific incidence and prevalence showed unimodal distributions. For incidence, the age of peak for Han was 10 years older than that for Mongolian while for 5-year prevalence they were the same (<xref rid="fig0001" ref-type="fig">Fig. 1</xref>).<fig id="fig0001" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Incidence and 5-year prevalence rates among male breast cancer patients grouped by ethnicity and age. (A) Incidence rates. (B) 5-year prevalence rates. All results are the rates of disease burden grouped by ethnic group and age group, and the error lines in each bar chart show 95 % confidence intervals. Incidence rate (per 100,000) was calculated as number of new cases of breast cancer each year among population at risk each year. 5-year prevalence rate (per 100,000) was calculated as the number of people alive who diagnosed during the past 5 years among the population each year.</p></caption><alt-text id="alt0001">Fig 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0001" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p></sec><sec id="sec0010"><label>3.3</label><title>Healthcare utilization</title><p id="para0020">Only 36.8 % of male patients recorded treatments for breast cancer, and 35.7 % of Han and 48.4 % of Mongolian in MBC were recorded for that (<italic toggle="yes">P</italic>=0.069). The overall cost and the cost of breast cancer annually per capita were $1734.5 (733.8&#8211;4820.9) and $507.4 (131.1&#8211;1804.9). The total cost of breast cancer per capita was $1282.6 (783.8&#8211;3811.6) for Han and $1447.2 (363.3&#8211;3215.2) for Mongolian (<italic toggle="yes">P</italic>=0.580). The cost on breast cancer per inpatient episode was $1127.0 (699.4&#8211;2076.4) for Han and $1057.8 (582.5&#8211;1937.9) for Mongolian (<italic toggle="yes">P</italic>=0.136), and per outpatient episode was $147.4 (22.3&#8211;681.1) for Han and $16.2 (4.3&#8211;35.1) for Mongolian (<italic toggle="yes">P</italic>=0.033). Mongolian patients had higher per outpatient episode overall cost ($9.9[4.3&#8211;28.9] vs $8.0[3.4&#8211;22.2], <italic toggle="yes">P</italic> = 0.009) and lower per outpatient episode cost for breast cancer ($16.2[4.3&#8211;35.1] vs $147.4[22.3&#8211;681.1], <italic toggle="yes">P</italic> = 0.033) than Han (<xref rid="tbl0002" ref-type="table">Table 2</xref>). Apart from the result that there was a significantly higher proportion of Mongolian patients who used chemotherapy (38.7% vs 25.0%, <italic toggle="yes">P</italic>=0.020), no significant disparities were observed in the treatment pattern (<xref rid="tbl0002" ref-type="table">Table 2</xref>).<table-wrap position="float" id="tbl0002" orientation="portrait"><label>Table 2</label><caption><p>Cost and treatment of male breast cancer patients in Inner Mongolia during 2012&#8211;2021 grouped by ethnicity.<xref rid="tb2fn1" ref-type="table-fn">a</xref></p></caption><alt-text id="alt0004">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top" colspan="1" rowspan="1">Cost</th><th colspan="2" align="left" valign="top" rowspan="1">Han (<italic toggle="yes">N</italic>=521)</th><th valign="top" colspan="1" rowspan="1">Mongolian (<italic toggle="yes">N</italic>=62)</th><th valign="top" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td valign="top" colspan="1" rowspan="1">Total per-capita cost, median (IQR), $</td><td colspan="2" align="left" valign="top" rowspan="1">7022.1 (3097.3, 14,877.8)</td><td valign="top" colspan="1" rowspan="1">9360.9 (4021.6, 18,212.7)</td><td valign="top" colspan="1" rowspan="1">0.105</td></tr><tr><td valign="top" colspan="1" rowspan="1">Total per-capita total cost on breast cancer, median (IQR), $</td><td colspan="2" align="left" valign="top" rowspan="1">1282.6 (783.8, 3811.6)</td><td valign="top" colspan="1" rowspan="1">1447.2 (363.3, 3215.2)</td><td valign="top" colspan="1" rowspan="1">0.580</td></tr><tr><td valign="top" colspan="1" rowspan="1">Annual per-capita cost, median (IQR), $</td><td colspan="2" align="left" valign="top" rowspan="1">1770.4 (748.5, 4993.2)</td><td valign="top" colspan="1" rowspan="1">2075.4 (893.8, 5140.4)</td><td valign="top" colspan="1" rowspan="1">0.454</td></tr><tr><td valign="top" colspan="1" rowspan="1">Annual per-capita cost on breast cancer, median (IQR), $</td><td colspan="2" align="left" valign="top" rowspan="1">496.6 (130.0, 2044.6)</td><td valign="top" colspan="1" rowspan="1">701.3 (183.8, 1082.3)</td><td valign="top" colspan="1" rowspan="1">0.870</td></tr><tr><td valign="top" colspan="1" rowspan="1">Patients with different treatment modality, n (%)</td><td colspan="2" align="left" valign="top" rowspan="1">186 (35.7)</td><td valign="top" colspan="1" rowspan="1">30 (48.4)</td><td valign="top" colspan="1" rowspan="1">0.069</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Surgery</td><td colspan="2" align="left" valign="top" rowspan="1">57 (11.0)</td><td valign="top" colspan="1" rowspan="1">5 (8.1)</td><td valign="top" colspan="1" rowspan="1">0.487</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Chemotherapy</td><td colspan="2" align="left" valign="top" rowspan="1">130 (25.0)</td><td valign="top" colspan="1" rowspan="1">24 (38.7)</td><td valign="top" colspan="1" rowspan="1">0.020</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Endocrine therapy</td><td colspan="2" align="left" valign="top" rowspan="1">66 (12.7)</td><td valign="top" colspan="1" rowspan="1">9 (14.5)</td><td valign="top" colspan="1" rowspan="1">0.681</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Radiotherapy</td><td colspan="2" align="left" valign="top" rowspan="1">13 (2.5)</td><td valign="top" colspan="1" rowspan="1">0 (0.0)</td><td valign="top" colspan="1" rowspan="1">0.380</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Targeted therapy</td><td colspan="2" align="left" valign="top" rowspan="1">16 (3.1)</td><td valign="top" colspan="1" rowspan="1">2 (3.2)</td><td valign="top" colspan="1" rowspan="1">1.000</td></tr><tr><td valign="top" colspan="1" rowspan="1">Per-capita cost of each treatment modality, median (IQR), $</td><td colspan="2" align="left" valign="top" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Surgery</td><td colspan="2" align="left" valign="top" rowspan="1">231.8 (123.7, 231.8)</td><td valign="top" colspan="1" rowspan="1">154.6 (92.7, 231.8)</td><td valign="top" colspan="1" rowspan="1">0.483</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Chemotherapy</td><td colspan="2" align="left" valign="top" rowspan="1">927.7 (251.1, 1956.6)</td><td valign="top" colspan="1" rowspan="1">660.7 (162.0, 1142.6)</td><td valign="top" colspan="1" rowspan="1">0.349</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Endocrine therapy</td><td colspan="2" align="left" valign="top" rowspan="1">142.1 (32.8, 1244.3)</td><td valign="top" colspan="1" rowspan="1">53.2 (20.4, 259.7)</td><td valign="top" colspan="1" rowspan="1">0.413</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Radiotherapy</td><td colspan="2" align="left" valign="top" rowspan="1">278.2 (154.6, 4605.9)</td><td valign="top" colspan="1" rowspan="1">0.0 (0.0, 0.0)</td><td valign="top" colspan="1" rowspan="1">&#8211;</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Targeted therapy</td><td colspan="2" align="left" valign="top" rowspan="1">2782.1 (1123.7, 7047.9)</td><td valign="top" colspan="1" rowspan="1">232.2 (0.6, 463.7)</td><td valign="top" colspan="1" rowspan="1">0.054</td></tr><tr><td valign="top" colspan="1" rowspan="1">Inpatients, median (IQR)</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Per-episode cost, $</td><td colspan="2" align="left" valign="top" rowspan="1">1147.7 (677.4, 1960.5)</td><td valign="top" colspan="1" rowspan="1">1227.9 (616.5, 2487.7)</td><td valign="top" colspan="1" rowspan="1">0.492</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Per-episode cost on breast cancer, $</td><td colspan="2" align="left" valign="top" rowspan="1">1127.0 (699.4, 2076.4)</td><td valign="top" colspan="1" rowspan="1">1057.8 (582.5, 1937.9)</td><td valign="top" colspan="1" rowspan="1">0.136</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Number of hospitalizations</td><td colspan="2" align="left" valign="top" rowspan="1">3.0 (1.0, 7.0)</td><td valign="top" colspan="1" rowspan="1">4.0 (1.0, 6.0)</td><td valign="top" colspan="1" rowspan="1">0.781</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Number of hospitalizations on breast cancer</td><td colspan="2" align="left" valign="top" rowspan="1">1.0 (1.0, 2.0)</td><td valign="top" colspan="1" rowspan="1">1.0 (1.0, 1.0)</td><td valign="top" colspan="1" rowspan="1">0.161</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Length of stay, days</td><td colspan="2" align="left" valign="top" rowspan="1">7.0 (4.0, 13.0)</td><td valign="top" colspan="1" rowspan="1">7.0 (4.0, 12.0)</td><td valign="top" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Length of stay on breast cancer, days</td><td colspan="2" align="left" valign="top" rowspan="1">6.0 (4.0, 12.0)</td><td valign="top" colspan="1" rowspan="1">6.0 (3.0, 13.0)</td><td valign="top" colspan="1" rowspan="1">0.399</td></tr><tr><td valign="top" colspan="1" rowspan="1">Outpatients, median (IQR)</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Per-episode cost, $</td><td colspan="2" align="left" valign="top" rowspan="1">8.0 (3.4, 22.2)</td><td valign="top" colspan="1" rowspan="1">9.9 (4.3, 28.9)</td><td valign="top" colspan="1" rowspan="1">0.009</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Per-episode cost for breast cancer, $</td><td colspan="2" align="left" valign="top" rowspan="1">147.4 (22.3, 681.1)</td><td valign="top" colspan="1" rowspan="1">16.2 (4.3, 35.1)</td><td valign="top" colspan="1" rowspan="1">0.033</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Number of visits</td><td colspan="2" align="left" valign="top" rowspan="1">57.5 (16.8, 110.0)</td><td valign="top" colspan="1" rowspan="1">52.0 (18.0, 119.5)</td><td valign="top" colspan="1" rowspan="1">0.810</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Number of visits for breast cancer</td><td colspan="2" align="left" valign="top" rowspan="1">1.0 (1.0, 2.0)</td><td valign="top" colspan="1" rowspan="1">1.0 (1.0, 2.0)</td><td valign="top" colspan="1" rowspan="1">0.805</td></tr></tbody></table><table-wrap-foot><fn id="tb2fn1"><label>a</label><p id="notep0010">The RMB-to-USD exchange rate is based on the exchange rate on July 15, 2020 ($1.0 USD = &#165;6.5).</p><p id="spara009">Abbreviation: IQR, interquartile range.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec0011"><label>3.4</label><title>Survival and prognosis</title><p id="para0021">The all-cause mortality for MBC was 50.8 per 1000 person-years (95% CI: 42.4&#8211;60.4), and breast cancer-specific mortality was 5.5 per 1000 person-years (95% CI: 3.0&#8211;9.3). Mongolian&#8217;s all-cause mortality (55.9[29.8&#8211;95.6] vs 50.0[40.9&#8211;60.5]) and breast cancer-specific (8.6[1.0&#8211;31.1] vs 5.2[2.6&#8211;9.4]) were insignificantly higher than Han&#8217;s, and no significant differences were observed in 5-, 3-, 2-, and 1-year survival rates either (<xref rid="tbl0003" ref-type="table">Table 3</xref>, Supplementary Table 8, Supplementary Table 9, and <xref rid="fig0002" ref-type="fig">Fig. 2</xref>).<table-wrap position="float" id="tbl0003" orientation="portrait"><label>Table 3</label><caption><p>Mortality outcomes and survival rates<xref rid="tb3fn1" ref-type="table-fn">a</xref> among male breast cancer patients grouped by ethnicity.</p></caption><alt-text id="alt0005">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top" colspan="1" rowspan="1">Characteristics</th><th valign="top" colspan="1" rowspan="1">Han</th><th valign="top" colspan="1" rowspan="1">Mongolian</th><th valign="top" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="4" align="left" valign="top" rowspan="1">Deaths, n (%)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;All-cause</td><td valign="top" colspan="1" rowspan="1">105 (20.2)</td><td valign="top" colspan="1" rowspan="1">13 (21.0)</td><td valign="top" colspan="1" rowspan="1">1</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Breast cancer-specific</td><td valign="top" colspan="1" rowspan="1">11 (2.1)</td><td valign="top" colspan="1" rowspan="1">2 (3.2)</td><td valign="top" colspan="1" rowspan="1">0.915</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">Mortality rates per 1 000 person-years, % (95% CI)</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;All-cause</td><td valign="top" colspan="1" rowspan="1">50.0 (40.9&#8211;60.5)</td><td valign="top" colspan="1" rowspan="1">55.9 (29.8&#8211;95.6)</td><td valign="top" colspan="1" rowspan="1">0.905</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Breast cancer-specific</td><td valign="top" colspan="1" rowspan="1">5.2 (2.6&#8211;9.4)</td><td valign="top" colspan="1" rowspan="1">8.6 (1.0&#8211;31.1)</td><td valign="top" colspan="1" rowspan="1">0.612</td></tr><tr><td valign="top" colspan="1" rowspan="1">Survival rate, % (95% CI)</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;1-year</td><td valign="top" colspan="1" rowspan="1">77.1 (73.1&#8211;81.4)</td><td valign="top" colspan="1" rowspan="1">76.8 (65.7&#8211;89.8)</td><td valign="top" colspan="1" rowspan="1">0.604</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;3-year</td><td valign="top" colspan="1" rowspan="1">83.3 (79.9&#8211;86.9)</td><td valign="top" colspan="1" rowspan="1">82.5 (73.2&#8211;93.1)</td><td valign="top" colspan="1" rowspan="1">0.886</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;5-year</td><td valign="top" colspan="1" rowspan="1">77.1 (73.1&#8211;81.4)</td><td valign="top" colspan="1" rowspan="1">76.8 (65.7&#8211;89.8)</td><td valign="top" colspan="1" rowspan="1">0.604</td></tr></tbody></table><table-wrap-foot><fn id="tb3fn1"><label>a</label><p id="notep0012">Survival rates were estimated using the Kaplan-Meier method.</p><p id="spara011a">Abbreviation: CI, confidence interval.</p></fn></table-wrap-foot></table-wrap><fig id="fig0002" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Kaplan&#8211;Meier survival estimates for male breast cancer patients in Inner Mongolia (2012&#8211;2021) by ethnicity.</p></caption><alt-text id="alt0002">Fig 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0002" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p><p id="para0022">After adjusted for covariates, male breast cancer patients residing in cities of a low GDP level were associated with increased breast-cancer specific mortality (HR, 22.5, [95% CI: 1.6&#8211;325.0]; <italic toggle="yes">P</italic>=0.022)(Supplementary Table 10) and patients diagnosed between the ages of 41&#8211;60 and over 61 were associated with decreased breast-cancer specific mortality (HR, 0.1, [95% CI: 0.0&#8211;0.6]; <italic toggle="yes">P</italic>=0.010)(Supplementary Table 10). No significant factor was observed in the model of hazard ratios for risk of all-cause mortality (<xref rid="tbl0004" ref-type="table">Table 4</xref>).<table-wrap position="float" id="tbl0004" orientation="portrait"><label>Table 4</label><caption><p>Hazard ratios for risk of all-cause mortality among male breast cancer patients.</p></caption><alt-text id="alt0006">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top" colspan="1" rowspan="1">Variable</th><th colspan="4" align="left" valign="top" rowspan="1">All-cause mortality<xref rid="tb4fn1" ref-type="table-fn">a</xref><hr/></th></tr><tr><th valign="top" colspan="1" rowspan="1"/><th valign="top" colspan="1" rowspan="1">Death events, n</th><th valign="top" colspan="1" rowspan="1">Person-year</th><th valign="top" colspan="1" rowspan="1">HR (95% CI) <xref rid="tb4fn1" ref-type="table-fn">a</xref></th><th valign="top" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td valign="top" colspan="1" rowspan="1">Age at diagnosis, years</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;18&#8211;40</td><td valign="top" colspan="1" rowspan="1">8</td><td valign="top" colspan="1" rowspan="1">21.7</td><td valign="top" colspan="1" rowspan="1">1.0 [Reference]</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;41&#8211;60</td><td valign="top" colspan="1" rowspan="1">31</td><td valign="top" colspan="1" rowspan="1">61.7</td><td valign="top" colspan="1" rowspan="1">0.7 (0.3&#8211;1.5)</td><td valign="top" colspan="1" rowspan="1">0.355</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;&#8805;61</td><td valign="top" colspan="1" rowspan="1">90</td><td valign="top" colspan="1" rowspan="1">179.0</td><td valign="top" colspan="1" rowspan="1">1.7 (0.8&#8211;3.6)</td><td valign="top" colspan="1" rowspan="1">0.169</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Ethnicity, n</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Han</td><td valign="top" colspan="1" rowspan="1">105</td><td valign="top" colspan="1" rowspan="1">220.0</td><td valign="top" colspan="1" rowspan="1">1.0 [Reference]</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Mongolian</td><td valign="top" colspan="1" rowspan="1">13</td><td valign="top" colspan="1" rowspan="1">22.7</td><td valign="top" colspan="1" rowspan="1">0.7 (0.4&#8211;1.3)</td><td valign="top" colspan="1" rowspan="1">0.300</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Others</td><td valign="top" colspan="1" rowspan="1">11</td><td valign="top" colspan="1" rowspan="1">19.6</td><td valign="top" colspan="1" rowspan="1">0.8 (0.4&#8211;1.6)</td><td valign="top" colspan="1" rowspan="1">0.537</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">GDP level of residence<xref rid="tb4fn2" ref-type="table-fn">b</xref></td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;High</td><td valign="top" colspan="1" rowspan="1">54</td><td valign="top" colspan="1" rowspan="1">134.0</td><td valign="top" colspan="1" rowspan="1">1.0 [Reference]</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Low</td><td valign="top" colspan="1" rowspan="1">75</td><td valign="top" colspan="1" rowspan="1">129.0</td><td valign="top" colspan="1" rowspan="1">0.9 (0.4&#8211;2.2)</td><td valign="top" colspan="1" rowspan="1">0.757</td></tr></tbody></table><table-wrap-foot><fn id="tb4fn1"><label>a</label><p id="notep0014">Stratified Cox model adjusted for age at diagnosis, ethnicity, GDP level of residence, alcohol consumption rate level, smoking rate level, Charlson comorbidity index, surgery, chemotherapy, endocrine therapy, targeted therapy, radiotherapy, stage (strata). The analysis included 628 patients (<italic toggle="yes">n</italic>=628), with two exclusions due to missing GDP data.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb4fn2"><label>b</label><p id="notep0015">GDP level of residence was stratified into two levels (high/low) by prefecture-level divisions according to the median of GDP per capita in 2020 (&#165;66,377.0 = $10,259.2). High: &#8805;&#165;66,377.0; Low: &lt;&#165;66,377.0.</p><p id="spara013">Abbreviations: CI, confidence interval; GDP, gross domestic product; HR, hazard ratio.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="sec0012"><label>4</label><title>Discussion</title><p id="para0023">Based on IMRHIP data from 2012 to 2021, we described the disease burden and healthcare utilization of male breast cancer in Inner Mongolia and concentrated on ethnic disparities between Han patients and Mongolian patients. Overall, no significant ethnic disparities were demonstrated in either aspect.</p><p id="para0024">We observed a moderate level of incidence of MBC in Inner Mongolia of China compared to other countries and regions. When compared with literature using different world standard populations, the ASR in this study have been transformed accordingly. The ASR of incidence of MBC (1.23 per 100,000) was first reported to be higher than previous studies in Asia including China<xref rid="bib0011" ref-type="bibr"><sup>11</sup></xref> (0.17 per 100,000 in Zhongshan, Guangdong Province in 2016), Singapore<xref rid="bib0046" ref-type="bibr"><sup>46</sup></xref> (0.40 per 100,000 in 2017), Japan<xref rid="bib0023" ref-type="bibr"><sup>23</sup></xref> (0.18 per 100,000 during 1988&#8211;2002) and Republic of Korea<xref rid="bib0008" ref-type="bibr"><sup>8</sup></xref> (0.22 per 100,000 in 2016). In contrast, it was close to the regions of high income in North America<xref rid="bib0047" ref-type="bibr"><sup>47</sup></xref> (1.26 per 100,000 in 2017) and Israel<xref rid="bib0023" ref-type="bibr"><sup>23</sup></xref> (1.24 per 100,000 during 1988&#8211;2002) as well as Asian Americans based on The Surveillance, Epidemiology, and End Results (SEER) database<xref rid="bib0019" ref-type="bibr"><sup>19</sup></xref> (0.66 per 100,000 during 1988&#8211;2000). Possible explanations are as follows. For one thing, previous studies were based on data from cancer registries<xref rid="bib0008" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="bib0010" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="bib0011" ref-type="bibr"><sup>11</sup></xref><sup>,</sup><xref rid="bib0019" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="bib0023" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bib0046" ref-type="bibr"><sup>46</sup></xref> in which the incidence of MBC might be underreported.<xref rid="bib0048" ref-type="bibr"><sup>48</sup></xref> Comparative studies about identifying cancer cases have found that insurance claims data can be used as an important implement in many countries, including China,<xref rid="bib0048" ref-type="bibr"><sup>48</sup></xref> Republic of Korea,<xref rid="bib0049" ref-type="bibr"><sup>49</sup></xref> the US,<xref rid="bib0050" ref-type="bibr"><sup>50</sup></xref> and Germany.<xref rid="bib0051" ref-type="bibr"><sup>51</sup></xref> Our study combined claim data and cancer registry data, thus reflecting the incidence more accurately. For another, population genetic susceptibility may play a role.<xref rid="bib0052" ref-type="bibr"><sup>52</sup></xref>
<italic toggle="yes">BRCA1/2</italic> (e.g. 5296del4 in <italic toggle="yes">BRCA1</italic> and 6174delT in <italic toggle="yes">BRCA2</italic>) mutation was considered as the crucial risk factor in breast cancer, and <italic toggle="yes">BRCA2</italic> mutations were more common in MBC.<xref rid="bib0053" ref-type="bibr"><sup>53</sup></xref> The <italic toggle="yes">BRCA2</italic> mutation was more frequently observed in China than in other Asian countries,<xref rid="bib0054" ref-type="bibr"><sup>54</sup></xref> resulting in a higher incidence in China.</p><p id="para0025">No significant ethnic disparities were found in incidence rates, survival rates, and prognosis patterns. It can be interpreted from the following perspectives. First, according to previous studies, a higher incidence of MBC may be associated with endocrine diseases like diabetes,<xref rid="bib0055" ref-type="bibr"><sup>55</sup></xref><sup>,</sup><xref rid="bib0056" ref-type="bibr"><sup>56</sup></xref> obesity, and disadvantaged lifestyles such as more alcohol and tobacco consumption.<xref rid="bib0057" ref-type="bibr"><sup>57</sup></xref> However, there were no significant differences in the proportion of diabetes (data not shown), smoking rate, and alcohol consumption rate between Mongolian and Han MBC patients in this study, and the latter two factors were also proved to have no significant ethnic differences in other studies.<xref rid="bib0058" ref-type="bibr"><sup>58</sup></xref><sup>,</sup><xref rid="bib0059" ref-type="bibr"><sup>59</sup></xref> Second, adjusted multivariate analysis indicated ethnicity was not significantly associated with higher risks of all-cause and breast cancer-specific mortality. Third, the aforementioned population genetic susceptibility is a potential factor, but no specific gene and ethnic discrepancies have been found. In sum, no significant ethnic disparities were revealed in the disease burden. However, differences related to economic factors should receive attention. Previous studies suggested that sociodemographic factors like income and insurance could neutralize ethnic disparities, and poverty was a significant predictor of breast cancer mortality,<xref rid="bib0021" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib0060" ref-type="bibr"><sup>60</sup></xref> with which the results of this study were consistent, warning of potential disease burden in Mongolians. Policymakers should pay great attention to economic factors and keep eliminating underlying ethnic disparities.</p><p id="para0026">We observed a lower level of healthcare utilization compared with other counties and regions. According to prior studies, the per-episode cost of visits on breast cancer in China ranged from $2009.3 to $3554.9 (from 1996 to 2015),<xref rid="bib0061" ref-type="bibr"><sup>61</sup></xref> with a median of approximately $3091.2 to $3864.0 (from 1996 to 2014).<xref rid="bib0062" ref-type="bibr"><sup>62</sup></xref> The mean cost on MBC per inpatient episode in Sichuan was $1925.0 (from 2015 to 2018),<xref rid="bib0063" ref-type="bibr"><sup>63</sup></xref> and the median cost in Jilin reached $3274.0 (2019).<xref rid="bib0064" ref-type="bibr"><sup>64</sup></xref> The only study that estimated hospital costs of male breast cancer at the US population level reported an average cost of $9059 per hospital visit (from 2012 to 2016).<xref rid="bib0013" ref-type="bibr"><sup>13</sup></xref> These figures were higher than those reported in this study. Possible explanations are as follows. First, different data sources may lead to bias. Most studies in China collected data from a single hospital or samples in certain areas, and few reported data at the provincial level<xref rid="bib0061" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bib0062" ref-type="bibr"><sup>62</sup></xref> like this study. Second, the economic level affects the allocation of medical resources<xref rid="bib0065" ref-type="bibr"><sup>65</sup></xref> and patients&#8217; healthcare-seeking behaviors. Disadvantaged patients are more likely to reduce expenses or quit treatment.<xref rid="bib0066" ref-type="bibr"><sup>66</sup></xref><sup>,</sup><xref rid="bib0067" ref-type="bibr"><sup>67</sup></xref> Inner Mongolia has an economic gap compared with the aforementioned areas. Third, advances in medical technology contribute to the increase in healthcare costs,<xref rid="bib0068" ref-type="bibr"><sup>68</sup></xref> and high per capita human capital loss is a factor of economic cost for high-income areas like the US, where people have better education attainment.<xref rid="bib0069" ref-type="bibr"><sup>69</sup></xref> Yet, in Inner Mongolia, medical technology and the quantity and quality of human health resources need to be improved.<xref rid="bib0070" ref-type="bibr"><sup>70</sup></xref></p><p id="para0027">We first reported ethnic differences in healthcare utilization among MBC patients,<xref rid="bib0013" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib0071" ref-type="bibr"><sup>71</sup></xref> and no significant disparities were observed. It can be illustrated from four aspects. First, health insurance significantly influences the cost by affecting patients&#8217; healthcare-seeking behaviors, which might be hindered if the patient is not being covered.<xref rid="bib0067" ref-type="bibr"><sup>67</sup></xref><sup>,</sup><xref rid="bib0072" ref-type="bibr">72</xref>, <xref rid="bib0073" ref-type="bibr">73</xref>, <xref rid="bib0074" ref-type="bibr">74</xref> However, the universal medical insurance system based on the National Basic Medical Insurance (NBMI) has covered over 95 % of the population in Inner Mongolia in 2020,<xref rid="bib0027" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib0075" ref-type="bibr"><sup>75</sup></xref> and 630 patients included in the study were all covered. Second, a high degree of ethnic mixing co-habitation<xref rid="bib0076" ref-type="bibr"><sup>76</sup></xref><sup>,</sup><xref rid="bib0077" ref-type="bibr"><sup>77</sup></xref> and demographically equitable medical resource distribution<xref rid="bib0065" ref-type="bibr"><sup>65</sup></xref><sup>,</sup><xref rid="bib0078" ref-type="bibr"><sup>78</sup></xref> assist both ethnic groups to access healthcare equally.<xref rid="bib0079" ref-type="bibr"><sup>79</sup></xref> Third, it is proven that the knowledge gaps of MBC<xref rid="bib0080" ref-type="bibr"><sup>80</sup></xref> might lead to stigmatization and embarrassment, causing refusal or non-adherence to medical assistance.<xref rid="bib0081" ref-type="bibr"><sup>81</sup></xref> However, few studies directly revealed the ethnic influence on knowledge access in MBC patients.<xref rid="bib0082" ref-type="bibr"><sup>82</sup></xref> Educational level indirectly helps understand the result as it potentially affects people&#8217;s awareness of disease and treatments.<xref rid="bib0082" ref-type="bibr"><sup>82</sup></xref> Studies have shown that educational equity in China at the ethnic level has made great progress since 1949.<xref rid="bib0083" ref-type="bibr"><sup>83</sup></xref> Due to favorable policies and sufficient funds resulting from economic development, the educational gap between Mongolian and Han has gradually narrowed.<xref rid="bib0084" ref-type="bibr"><sup>84</sup></xref> Lastly, favorable marital status might affect MBC patients&#8217; healthcare-seeking behaviors by offering psychosocial and emotional support.<xref rid="bib0082" ref-type="bibr"><sup>82</sup></xref><sup>,</sup><xref rid="bib0085" ref-type="bibr">85</xref>, <xref rid="bib0086" ref-type="bibr">86</xref>, <xref rid="bib0087" ref-type="bibr">87</xref> 630 patients in this study displayed no significant ethnic difference in marital status, which might contribute to the understanding of our finding. Overall, this study highlighted the equity in utilization for MBC patients in Inner Mongolia and provided directions for further development of health equity.</p><p id="para0028">To our knowledge, this is the first study to uncover ethnic disparities in disease burden and healthcare utilization of male breast cancer based on 630 patients from 9.08 million general population in China. Our results should be considered within the context of study limitations. First, case ascertainment was limited due to the unavailability of laboratory data and imaging information by medical insurance. However, previous studies using NBMI to identify cancer cases have verified sensitivities and positive predictive values (PPVs) above 90 %.<xref rid="bib0048" ref-type="bibr"><sup>48</sup></xref><sup>,</sup><xref rid="bib0088" ref-type="bibr"><sup>88</sup></xref> Second, overseas treatments and part of patient-funded treatment programs, such as traditional Chinese medicine and medicine purchased through the Internet, are not included in the NBMI. Still, the NBMI provides a good picture of breast cancer patients&#8217; utilization of regional health services. Third, the small sample size of Mongolian males and patients, especially those with follow-ups for more than 5 years, led to low statistical power in the analyses, calling for larger sample sizes. Moreover, tumor grade and subtype were not available, influencing further interpretation of our results. However, the results of disease burden carry substantial importance.<xref rid="bib0089" ref-type="bibr"><sup>89</sup></xref> Finally, the aforementioned findings were only observed in Inner Mongolia, which requires external verification in other populations.</p></sec><sec id="sec0013"><label>5</label><title>Conclusions</title><p id="para0029">In conclusion, we examined the ethnic differences in disease burden and healthcare utilization of MBC based on large-scale population-based data in Inner Mongolia. We reported the incidence, 5-year prevalence, prognosis and healthcare utilization in MBC, and the disparity of disease burden and medical utilization between Mongolian and Han MBC patients is not statistically significant. However, the study still calls for a greater focus on potential ethnic disparities due to the crucial influence of economic factors and different healthcare-seeking behavior patterns. Further research is needed to explore the potential mechanisms and provide policymakers with more precise recommendations.</p></sec><sec sec-type="COI-statement" id="coi0001"><title>Declaration of competing interests</title><p id="para0031">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors L.G.Z. and W.M.Y. are employees of China Unicom Digital Intelligence Medical Technology Co., Ltd. and Peking University Health Information Technology Co., Ltd., respectively. L.G.Z. serves as a Product Manager, and W.M.Y. serves as a Developmental Engineer. Their positions have not influenced the content or outcomes of this study. This research did not receive any financial support from the aforementioned companies.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><label>1</label><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Baade</surname><given-names>P.D.</given-names></name><etal/></person-group><article-title>Cancer statistics in China, 2015</article-title><source>CA <italic toggle="yes">Cancer J Clin</italic></source><volume>66</volume><issue>2</issue><year>2016</year><fpage>115</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.3322/caac.21338</pub-id><pub-id pub-id-type="pmid">26808342</pub-id></element-citation></ref><ref id="bib0002"><label>2</label><element-citation publication-type="journal" id="sbref0002"><person-group person-group-type="author"><name name-style="western"><surname>Giaquinto</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Sung</surname><given-names>H.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>K.D.</given-names></name><etal/></person-group><article-title>Breast cancer statistics, 2022</article-title><source>CA <italic toggle="yes">Cancer J Clin</italic></source><volume>72</volume><issue>6</issue><year>2022</year><fpage>524</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.3322/caac.21754</pub-id><pub-id pub-id-type="pmid">36190501</pub-id></element-citation></ref><ref id="bib0003"><label>3</label><mixed-citation publication-type="other" id="sbref0003">Noone A.M., Howlader N., Krapcho M., et al. SEER Cancer Statistics Review 1975&#8211;2015. Accessed 12 May 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://seer.cancer.gov/archive/csr/1975_2015/index.html" id="interref0002">https://seer.cancer.gov/archive/csr/1975_2015/index.html</ext-link>.</mixed-citation></ref><ref id="bib0004"><label>4</label><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><name name-style="western"><surname>Corrigan</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Mainwaring</surname><given-names>W.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>A.B.</given-names></name><etal/></person-group><article-title>Exclusion of men from randomized phase III breast cancer clinical trials</article-title><source>Oncologist</source><volume>25</volume><issue>6</issue><year>2020</year><fpage>e990</fpage><lpage>e992</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2019-0871</pub-id><pub-id pub-id-type="pmid">32272505</pub-id><pub-id pub-id-type="pmcid">PMC7288651</pub-id></element-citation></ref><ref id="bib0005"><label>5</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name name-style="western"><surname>Hassett</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Somerfield</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>E.R.</given-names></name><etal/></person-group><article-title>Management of male breast cancer: ASCO guideline</article-title><source>J Clin Oncol</source><volume>38</volume><issue>16</issue><year>2020</year><fpage>1849</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1200/JCO.19.03120</pub-id><pub-id pub-id-type="pmid">32058842</pub-id></element-citation></ref><ref id="bib0006"><label>6</label><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name name-style="western"><surname>Ruddy</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Winer</surname><given-names>E.P.</given-names></name></person-group><article-title>Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship</article-title><source>Ann Oncol</source><volume>24</volume><issue>6</issue><year>2013</year><fpage>1434</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdt025</pub-id><pub-id pub-id-type="pmid">23425944</pub-id></element-citation></ref><ref id="bib0007"><label>7</label><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name name-style="western"><surname>Kiluk</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C.K.</given-names></name><etal/></person-group><article-title>Male breast cancer: management and follow-up recommendations</article-title><source>Breast J</source><volume>17</volume><issue>5</issue><year>2011</year><fpage>503</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1111/j.1524-4741.2011.01148.x</pub-id><pub-id pub-id-type="pmid">21883641</pub-id></element-citation></ref><ref id="bib0008"><label>8</label><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>E.G.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>M.C.</given-names></name><etal/></person-group><article-title>Comparing the characteristics and outcomes of male and female breast cancer patients in Korea: korea Central Cancer Registry</article-title><source>Cancer Res Treat</source><volume>52</volume><issue>3</issue><year>2020</year><fpage>739</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.4143/crt.2019.639</pub-id><pub-id pub-id-type="pmid">32054149</pub-id><pub-id pub-id-type="pmcid">PMC7373857</pub-id></element-citation></ref><ref id="bib0009"><label>9</label><element-citation publication-type="journal" id="sbref0009"><person-group person-group-type="author"><name name-style="western"><surname>Kwong</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chau</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Mang</surname><given-names>O.W.K.</given-names></name><etal/></person-group><article-title>Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997&#8211;2006</article-title><source>Ann Surg Oncol</source><volume>21</volume><issue>4</issue><year>2014</year><fpage>1246</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1245/s10434-013-3377-8</pub-id><pub-id pub-id-type="pmid">24337541</pub-id></element-citation></ref><ref id="bib0010"><label>10</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Incidence and mortality of male breast cancer in Hubei Province from 2012 to 2015</article-title><source>Cancer Res Prev Treat</source><volume>48</volume><issue>11</issue><year>2021</year><fpage>1012</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.3971/j.issn.1000-8578.2021.21.0615</pub-id></element-citation></ref><ref id="bib0011"><label>11</label><element-citation publication-type="journal" id="sbref0011"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name></person-group><article-title>Trend of breast cancer incidence from 2000 to 2016 in Zhongshan City of Guangdong Province</article-title><source>China Cancer</source><volume>30</volume><issue>08</issue><year>2021</year><fpage>608</fpage><lpage>613</lpage></element-citation></ref><ref id="bib0012"><label>12</label><element-citation publication-type="journal" id="sbref0012"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The 5-year incidence of male breast cancer in Southwest of China from 2007 to 2011</article-title><source>Chin-Ger J Clin Oncol</source><volume>12</volume><year>2013</year><fpage>524</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1007/s10330-013-1234-7</pub-id></element-citation></ref><ref id="bib0013"><label>13</label><element-citation publication-type="journal" id="sbref0013"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S.-K.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Chun</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C.</given-names></name></person-group><article-title>Hospital outcomes of male breast cancer in the United States</article-title><source>Am J Manag Care</source><volume>27</volume><issue>6</issue><year>2021</year><fpage>e181</fpage><lpage>e187</lpage><pub-id pub-id-type="doi">10.37765/ajmc.2021.88666</pub-id><pub-id pub-id-type="pmid">34156221</pub-id></element-citation></ref><ref id="bib0014"><label>14</label><element-citation publication-type="journal" id="sbref0014"><person-group person-group-type="author"><name name-style="western"><surname>Giordano</surname><given-names>S.H.</given-names></name></person-group><article-title>Breast cancer in men</article-title><source>N Engl J Med</source><volume>378</volume><issue>24</issue><year>2018</year><fpage>2311</fpage><lpage>2320</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1707939</pub-id><pub-id pub-id-type="pmid">29897847</pub-id></element-citation></ref><ref id="bib0015"><label>15</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name name-style="western"><surname>McCracken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.S.</given-names></name><etal/></person-group><article-title>Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnic ities</article-title><source>CA <italic toggle="yes">Cancer J Clin</italic></source><volume>57</volume><issue>4</issue><year>2007</year><fpage>190</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.3322/canjclin.57.4.190</pub-id><pub-id pub-id-type="pmid">17626117</pub-id></element-citation></ref><ref id="bib0016"><label>16</label><element-citation publication-type="journal" id="sbref0016"><person-group person-group-type="author"><name name-style="western"><surname>Shoemaker</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Weir</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Romieu</surname><given-names>I.</given-names></name></person-group><article-title>Differences in breast cancer incidence among young women aged 20&#8211;49 years by stage and tumor characteristics, age, race, and ethnicity, 2004&#8211;2013</article-title><source>Breast Cancer Res Treat</source><volume>169</volume><issue>3</issue><year>2018</year><fpage>595</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1007/s10549-018-4699-9</pub-id><pub-id pub-id-type="pmid">29445940</pub-id><pub-id pub-id-type="pmcid">PMC5955792</pub-id></element-citation></ref><ref id="bib0017"><label>17</label><element-citation publication-type="journal" id="sbref0017"><person-group person-group-type="author"><name name-style="western"><surname>Ellington</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Henley</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>L.C.</given-names></name></person-group><article-title>Trends in breast cancer mortality by race/ethnicity, age, and US census region, United States-1999&#8211;2020</article-title><source>Cancer</source><volume>129</volume><issue>1</issue><year>2022</year><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1002/cncr.34503</pub-id><pub-id pub-id-type="pmid">36309838</pub-id><pub-id pub-id-type="pmcid">PMC10128100</pub-id></element-citation></ref><ref id="bib0018"><label>18</label><element-citation publication-type="journal" id="sbref0018"><person-group person-group-type="author"><name name-style="western"><surname>Ellington</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Henley</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J.W.</given-names></name></person-group><article-title>Breast cancer survival among males by race, ethnicity, age, geographic region, and stage-United States, 2007-2016</article-title><source>MMWR Morb Mortal Wkly Rep</source><volume>69</volume><issue>41</issue><year>2020</year><fpage>1481</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6941a2</pub-id><pub-id pub-id-type="pmid">33056954</pub-id><pub-id pub-id-type="pmcid">PMC7561088</pub-id></element-citation></ref><ref id="bib0019"><label>19</label><element-citation publication-type="journal" id="sbref0019"><person-group person-group-type="author"><name name-style="western"><surname>O'Malley</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shema</surname><given-names>S.</given-names></name><name name-style="western"><surname>White</surname><given-names>E.</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>S.</given-names></name></person-group><article-title>Incidence of male breast cancer in California, 1988&#8211;2000: racial/ethnic variation in 1759 men</article-title><source>Breast Cancer Res Treat</source><volume>93</volume><issue>2</issue><year>2005</year><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/s10549-005-4517-z</pub-id><pub-id pub-id-type="pmid">16187234</pub-id></element-citation></ref><ref id="bib0020"><label>20</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name name-style="western"><surname>O'Malley</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Prehn</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Shema</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>S.L.</given-names></name></person-group><article-title>Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma</article-title><source>Cancer</source><volume>94</volume><issue>11</issue><year>2002</year><fpage>2836</fpage><lpage>2843</lpage><pub-id pub-id-type="doi">10.1002/cncr.10521</pub-id><pub-id pub-id-type="pmid">12115370</pub-id></element-citation></ref><ref id="bib0021"><label>21</label><element-citation publication-type="journal" id="sbref0021"><person-group person-group-type="author"><name name-style="western"><surname>Parise</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Caggiano</surname><given-names>V.</given-names></name></person-group><article-title>The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts</article-title><source>Cancer</source><volume>129</volume><issue>5</issue><year>2023</year><fpage>750</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1002/cncr.34592</pub-id><pub-id pub-id-type="pmid">36597579</pub-id></element-citation></ref><ref id="bib0022"><label>22</label><element-citation publication-type="journal" id="sbref0022"><person-group person-group-type="author"><name name-style="western"><surname>Chavez-MacGregor</surname><given-names>M.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Lichtensztajn</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hortobagyi</surname><given-names>G.N.</given-names></name><name name-style="western"><surname>Giordano</surname><given-names>S.H.</given-names></name></person-group><article-title>Male breast cancer according to tumor subtype and race</article-title><source>Cancer</source><volume>119</volume><issue>9</issue><year>2013</year><fpage>1611</fpage><lpage>1617</lpage><pub-id pub-id-type="doi">10.1002/cncr.27905</pub-id><pub-id pub-id-type="pmid">23341341</pub-id><pub-id pub-id-type="pmcid">PMC3971835</pub-id></element-citation></ref><ref id="bib0023"><label>23</label><element-citation publication-type="journal" id="sbref0023"><person-group person-group-type="author"><name name-style="western"><surname>Ly</surname><given-names>D.</given-names></name><name name-style="western"><surname>Forman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brinton</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M.B.</given-names></name></person-group><article-title>An international comparison of male and female breast cancer incidence rates</article-title><source>Intl J Cancer</source><volume>132</volume><issue>8</issue><year>2013</year><fpage>1918</fpage><lpage>1926</lpage><pub-id pub-id-type="doi">10.1002/ijc.27841</pub-id><pub-id pub-id-type="pmcid">PMC3553266</pub-id><pub-id pub-id-type="pmid">22987302</pub-id></element-citation></ref><ref id="bib0024"><label>24</label><element-citation publication-type="journal" id="sbref0024"><person-group person-group-type="author"><name name-style="western"><surname>Iqbal</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ginsburg</surname><given-names>O.</given-names></name><name name-style="western"><surname>Rochon</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>P.</given-names></name><name name-style="western"><surname>Narod</surname><given-names>S.A.</given-names></name></person-group><article-title>Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States</article-title><source>JAMA</source><volume>313</volume><issue>2</issue><year>2015</year><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.17322</pub-id><pub-id pub-id-type="pmid">25585328</pub-id></element-citation></ref><ref id="bib0025"><label>25</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020</article-title><source>Cancer Commun (Lond)</source><volume>41</volume><issue>11</issue><year>2021</year><fpage>1183</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1002/cac2.12207</pub-id><pub-id pub-id-type="pmid">34399040</pub-id><pub-id pub-id-type="pmcid">PMC8626596</pub-id></element-citation></ref><ref id="bib0026"><label>26</label><element-citation publication-type="journal" id="sbref0026"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>H.Z.</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>L.Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.J.</given-names></name><etal/></person-group><article-title>Association of ethnicity, sex, and age with cancer diagnoses and health care utilization among children in Inner Mongolia, China</article-title><source>JAMA Netw Open</source><volume>5</volume><issue>9</issue><year>2022</year><object-id pub-id-type="publisher-id">e2231182</object-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.31182</pub-id><pub-id pub-id-type="pmcid">PMC9468889</pub-id><pub-id pub-id-type="pmid">36094504</pub-id></element-citation></ref><ref id="bib0027"><label>27</label><element-citation publication-type="journal" id="sbref0027"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Higher disease burden and lower utilization in Mongolian with breast cancer: a 9-year retrospective cohort study of 18.19 million adults in China</article-title><source>Int J Surg</source><volume>110</volume><issue>8</issue><year>2024</year><fpage>4588</fpage><lpage>4597</lpage><pub-id pub-id-type="doi">10.1097/js9.0000000000001478</pub-id><pub-id pub-id-type="pmid">38608032</pub-id><pub-id pub-id-type="pmcid">PMC11325962</pub-id></element-citation></ref><ref id="bib0028"><label>28</label><element-citation publication-type="journal" id="sbref0028"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y.</given-names></name></person-group><article-title>Summary on experience on integrating urban and rural resident medical insurance in Inner Mongolia</article-title><source>Chin Health Economics</source><volume>38</volume><issue>02</issue><year>2019</year><fpage>34</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.7664/CHE20190209</pub-id></element-citation></ref><ref id="bib0029"><label>29</label><element-citation publication-type="journal" id="sbref0029"><person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Pompei</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ales</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>MacKenzie</surname><given-names>C.R.</given-names></name></person-group><article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title><source>J Chronic Dis</source><volume>40</volume><issue>5</issue><year>1987</year><fpage>373</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/0021-9681(87)90171-8</pub-id><pub-id pub-id-type="pmid">3558716</pub-id></element-citation></ref><ref id="bib0030"><label>30</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name name-style="western"><surname>Quan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sundararajan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Halfon</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data</article-title><source>Med Care</source><volume>43</volume><issue>11</issue><year>2005</year><fpage>1130</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1097/01.mlr.0000182534.19832.83</pub-id><pub-id pub-id-type="pmid">16224307</pub-id></element-citation></ref><ref id="bib0031"><label>31</label><element-citation publication-type="book" id="sbref0031"><person-group person-group-type="author"><collab>Bureau of Statistics of Inner Mongolia Autonomous Region</collab></person-group><source>Annual data of gross regional product-city data in Inner Mongolia Autonomous Region</source><year>2022</year><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://tj.nmg.gov.cn/datashow/easyquery/easyquery.htm?cn=B0103" id="interref0003">http://tj.nmg.gov.cn/datashow/easyquery/easyquery.htm?cn=B0103</ext-link><comment>Accessed December 2, 2024</comment></element-citation></ref><ref id="bib0032"><label>32</label><element-citation publication-type="book" id="sbref0032"><person-group person-group-type="author"><collab>Oncology CSoC</collab></person-group><part-title>Breast cancer guidelines of Chinese Society of Clinical Oncology</part-title><year>2021</year><publisher-name>People's Medical Publishing House</publisher-name></element-citation></ref><ref id="bib0033"><label>33</label><element-citation publication-type="journal" id="sbref0033"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China</article-title><source>EClinicalMedicine</source><volume>20</volume><year>2020</year><object-id pub-id-type="publisher-id">100312</object-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2020.100312</pub-id><pub-id pub-id-type="pmcid">PMC7090368</pub-id><pub-id pub-id-type="pmid">32215367</pub-id></element-citation></ref><ref id="bib0034"><label>34</label><element-citation publication-type="journal" id="sbref0034"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>F.</given-names></name></person-group><article-title>Comprehensive management guideline for breast cancer follow-up and healthcare (2022 edition)</article-title><source>Chin J Oncol</source><volume>44</volume><issue>1</issue><year>2022</year><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.3760/cma.j.cn112152-20211029-00798</pub-id><pub-id pub-id-type="pmid">35073646</pub-id></element-citation></ref><ref id="bib0035"><label>35</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study</article-title><source>PLoS Med</source><volume>17</volume><issue>8</issue><year>2020</year><object-id pub-id-type="publisher-id">e1003180</object-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1003180</pub-id><pub-id pub-id-type="pmcid">PMC7410202</pub-id><pub-id pub-id-type="pmid">32760065</pub-id></element-citation></ref><ref id="bib0036"><label>36</label><element-citation publication-type="journal" id="sbref0036"><person-group person-group-type="author"><name name-style="western"><surname>Clopper</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>E.S.</given-names></name></person-group><article-title>The use of confidence or fiducial limits illustrated in the case of the binomial</article-title><source>Biometrika</source><volume>26</volume><issue>4</issue><year>1934</year><fpage>404</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1093/biomet/26.4.404</pub-id></element-citation></ref><ref id="bib0037"><label>37</label><mixed-citation publication-type="other" id="sbref0037">Ahmad O.B., Boschi-Pinto C., Lopez A.D., Murray C.J., Inoue M. Age standardization of rates: a new WHO standard. Accessed 1 May 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/gpe_discussion_paper_series_paper31_2001_age_standardization_rates.pdf" id="interref0004">https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/gpe_discussion_paper_series_paper31_2001_age_standardization_rates.pdf</ext-link>.</mixed-citation></ref><ref id="bib0038"><label>38</label><mixed-citation publication-type="other" id="sbref0038">National Cancer Institute. Standard populations-19 age groups. Accessed 20 Feb 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://seer.cancer.gov/stdpopulations/stdpop.19ages.html" id="interref0005">https://seer.cancer.gov/stdpopulations/stdpop.19ages.html</ext-link>.</mixed-citation></ref><ref id="bib0039"><label>39</label><mixed-citation publication-type="other" id="sbref1038">GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. <italic toggle="yes">Lancet</italic>. 2018;392(10159):1995&#8211;2051. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(18)32278-5" id="interref1001">doi:10.1016/S0140-6736(18)32278-5</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(18)32278-5</pub-id><pub-id pub-id-type="pmcid">PMC6227915</pub-id><pub-id pub-id-type="pmid">30496106</pub-id></mixed-citation></ref><ref id="bib0040"><label>40</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name name-style="western"><surname>Swaminathan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>H.</given-names></name></person-group><article-title>Statistical methods for cancer survival analysis</article-title><source>IARC Sci. Publ.</source><volume>162</volume><year>2011</year><fpage>7</fpage><lpage>13</lpage><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://publications.iarc.who.int/_publications/media/download/3711/671ad54c62e4ce0465dcd2108976db01b7a7e774.pdf" id="interref0006">https://publications.iarc.who.int/_publications/media/download/3711/671ad54c62e4ce0465dcd2108976db01b7a7e774.pdf</ext-link><pub-id pub-id-type="pmid">21675401</pub-id></element-citation></ref><ref id="bib0041"><label>41</label><element-citation publication-type="journal" id="sbref0041"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gefeller</surname><given-names>O.</given-names></name></person-group><article-title>Deriving more up-to-date estimates of long-term patient survival</article-title><source>J Clin Epidemiol</source><volume>50</volume><issue>2</issue><year>1997</year><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/s0895-4356(97)00280-1</pub-id><pub-id pub-id-type="pmid">9120515</pub-id></element-citation></ref><ref id="bib0042"><label>42</label><element-citation publication-type="journal" id="sbref0042"><person-group person-group-type="author"><name name-style="western"><surname>Bollschweiler</surname><given-names>E.</given-names></name></person-group><article-title>Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery</article-title><source>Langenbecks Arch Surg</source><volume>388</volume><issue>4</issue><year>2003</year><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1007/s00423-003-0410-6</pub-id><pub-id pub-id-type="pmid">12920602</pub-id></element-citation></ref><ref id="bib0043"><label>43</label><element-citation publication-type="journal" id="sbref0043"><person-group person-group-type="author"><name name-style="western"><surname>Parkin</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Hakulinen</surname><given-names>T.</given-names></name></person-group><article-title>Cancer registration: principles and methods. Analysis of survival</article-title><source>IARC Sci Publ</source><issue>95</issue><year>1991</year><fpage>159</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">1894319</pub-id></element-citation></ref><ref id="bib0044"><label>44</label><element-citation publication-type="journal" id="sbref0044"><person-group person-group-type="author"><name name-style="western"><surname>von Elm</surname><given-names>E.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Egger</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title><source>Lancet</source><volume>370</volume><issue>9596</issue><year>2007</year><fpage>1453</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61602-X</pub-id><pub-id pub-id-type="pmid">18064739</pub-id></element-citation></ref><ref id="bib0045"><label>45</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name name-style="western"><surname>Mathew</surname><given-names>G.</given-names></name><name name-style="western"><surname>Agha</surname><given-names>R.</given-names></name><name name-style="western"><surname>Albrecht</surname><given-names>J.</given-names></name><etal/></person-group><article-title>STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery</article-title><source>Intl J surgery (London, England)</source><volume>96</volume><year>2012</year><object-id pub-id-type="publisher-id">106165</object-id><pub-id pub-id-type="doi">10.1016/j.ijsu.2021.106165</pub-id><pub-id pub-id-type="pmid">34774726</pub-id></element-citation></ref><ref id="bib0046"><label>46</label><element-citation publication-type="journal" id="sbref0046"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Verkooijen</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Chia</surname><given-names>K.-S.</given-names></name><etal/></person-group><article-title>Incidence and outcome of male breast cancer: an international population-based study</article-title><source>J Clin Oncol</source><volume>29</volume><issue>33</issue><year>2011</year><fpage>4381</fpage><lpage>4386</lpage><pub-id pub-id-type="doi">10.1200/JCO.2011.36.8902</pub-id><pub-id pub-id-type="pmid">21969512</pub-id></element-citation></ref><ref id="bib0047"><label>47</label><element-citation publication-type="journal" id="sbref0047"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990-2017</article-title><source>Breast Cancer Res Treat</source><volume>180</volume><issue>2</issue><year>2020</year><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1007/s10549-020-05561-1</pub-id><pub-id pub-id-type="pmid">32056055</pub-id></element-citation></ref><ref id="bib0048"><label>48</label><element-citation publication-type="journal" id="sbref0048"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Identification of cancer patients using claims data from health insurance systems: a real-world comparative study</article-title><source>Chin J Cancer Res</source><volume>31</volume><issue>4</issue><year>2019</year><fpage>699</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.21147/j.issn.1000-9604.2019.04.13</pub-id><pub-id pub-id-type="pmid">31564812</pub-id><pub-id pub-id-type="pmcid">PMC6736657</pub-id></element-citation></ref><ref id="bib0049"><label>49</label><element-citation publication-type="journal" id="sbref0049"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>M.</given-names></name><name name-style="western"><surname>Back</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>Validation of cancer diagnosis based on the national health insurance service database versus the national cancer registry database in Korea</article-title><source>Cancer Res Treat</source><volume>54</volume><issue>2</issue><year>2022</year><fpage>352</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.4143/crt.2021.044</pub-id><pub-id pub-id-type="pmid">34353000</pub-id><pub-id pub-id-type="pmcid">PMC9016317</pub-id></element-citation></ref><ref id="bib0050"><label>50</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name name-style="western"><surname>Garvin</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Herget</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Hashibe</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Linkage between Utah all payers claims database and central cancer registry</article-title><source>Health Serv Res</source><volume>54</volume><issue>3</issue><year>2019</year><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1111/1475-6773.13114</pub-id><pub-id pub-id-type="pmid">30675913</pub-id><pub-id pub-id-type="pmcid">PMC6505409</pub-id></element-citation></ref><ref id="bib0051"><label>51</label><element-citation publication-type="journal" id="sbref0051"><person-group person-group-type="author"><name name-style="western"><surname>Oppelt</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Luttmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kraywinkel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Haug</surname><given-names>U.</given-names></name></person-group><article-title>Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data</article-title><source>BMC Med Res Methodol</source><volume>19</volume><issue>1</issue><year>2019</year><fpage>142</fpage><pub-id pub-id-type="doi">10.1186/s12874-019-0784-y</pub-id><pub-id pub-id-type="pmid">31286896</pub-id><pub-id pub-id-type="pmcid">PMC6615087</pub-id></element-citation></ref><ref id="bib0052"><label>52</label><element-citation publication-type="journal" id="sbref0052"><person-group person-group-type="author"><name name-style="western"><surname>Rizzolo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Silvestri</surname><given-names>V.</given-names></name><name name-style="western"><surname>Tommasi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Male breast cancer: genetics, epigenetics, and ethical aspects</article-title><source>Ann Oncol</source><volume>24</volume><year>2013</year><fpage>viii75</fpage><lpage>viii82</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdt316</pub-id><pub-id pub-id-type="pmid">24131976</pub-id></element-citation></ref><ref id="bib0053"><label>53</label><element-citation publication-type="journal" id="sbref0053"><person-group person-group-type="author"><name name-style="western"><surname>Liede</surname><given-names>A.</given-names></name><name name-style="western"><surname>Karlan</surname><given-names>B.Y.</given-names></name><name name-style="western"><surname>Narod</surname><given-names>S.A.</given-names></name></person-group><article-title>Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature</article-title><source>J Clin Oncol</source><volume>22</volume><issue>4</issue><year>2004</year><fpage>735</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1200/JCO.2004.05.055</pub-id><pub-id pub-id-type="pmid">14966099</pub-id></element-citation></ref><ref id="bib0054"><label>54</label><element-citation publication-type="journal" id="sbref0054"><person-group person-group-type="author"><name name-style="western"><surname>Kwong</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>V.Y.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>J.C.W.</given-names></name><etal/></person-group><article-title>Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries</article-title><source>J Med Genet</source><volume>53</volume><issue>1</issue><year>2016</year><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103132</pub-id><pub-id pub-id-type="pmid">26187060</pub-id><pub-id pub-id-type="pmcid">PMC4681590</pub-id></element-citation></ref><ref id="bib0055"><label>55</label><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name name-style="western"><surname>Orr</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lemnrau</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cooke</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk</article-title><source>Nat Genet</source><volume>44</volume><issue>11</issue><year>2012</year><fpage>1182</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1038/ng.2417</pub-id><pub-id pub-id-type="pmid">23001122</pub-id><pub-id pub-id-type="pmcid">PMC3722904</pub-id></element-citation></ref><ref id="bib0056"><label>56</label><element-citation publication-type="journal" id="sbref0056"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gandhi</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Suissa</surname><given-names>S.</given-names></name></person-group><article-title>Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis</article-title><source>Arthritis Res Ther</source><volume>17</volume><issue>1</issue><year>2015</year><fpage>212</fpage><pub-id pub-id-type="doi">10.1186/s13075-015-0728-9</pub-id><pub-id pub-id-type="pmid">26271620</pub-id><pub-id pub-id-type="pmcid">PMC4536786</pub-id></element-citation></ref><ref id="bib0057"><label>57</label><element-citation publication-type="journal" id="sbref0057"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study</article-title><source>BMC Public Health</source><volume>12</volume><year>2012</year><fpage>499</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-12-499</pub-id><pub-id pub-id-type="pmid">22759741</pub-id><pub-id pub-id-type="pmcid">PMC3489619</pub-id></element-citation></ref><ref id="bib0058"><label>58</label><element-citation publication-type="journal" id="sbref0058"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations</article-title><source>BMC Public Health</source><volume>16</volume><year>2016</year><fpage>294</fpage><pub-id pub-id-type="doi">10.1186/s12889-016-2965-5</pub-id><pub-id pub-id-type="pmid">27036609</pub-id><pub-id pub-id-type="pmcid">PMC4818445</pub-id></element-citation></ref><ref id="bib0059"><label>59</label><element-citation publication-type="journal" id="sbref0059"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Survey and analysis of drinking among adults in Hulunbuir Mongolian region</article-title><source>Modern Prev Med</source><volume>40</volume><issue>04</issue><year>2013</year><fpage>697</fpage><lpage>700</lpage></element-citation></ref><ref id="bib0060"><label>60</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name name-style="western"><surname>Sineshaw</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Flanders</surname><given-names>W.D.</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Black/white disparities in receipt of treatment and survival among men with early-stage breast cancer</article-title><source>J Clin Oncol</source><volume>33</volume><issue>21</issue><year>2015</year><fpage>2337</fpage><lpage>2344</lpage><pub-id pub-id-type="doi">10.1200/jco.2014.60.5584</pub-id><pub-id pub-id-type="pmid">25940726</pub-id></element-citation></ref><ref id="bib0061"><label>61</label><element-citation publication-type="journal" id="sbref0061"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name><etal/></person-group><article-title>A study of the economic burden of breast cancer in China over the past two decades. Article in Chinese</article-title><source>Chin J Prev Control Chronic Diseases</source><volume>25</volume><issue>02</issue><year>2017</year><fpage>143</fpage><lpage>146</lpage></element-citation></ref><ref id="bib0062"><label>62</label><element-citation publication-type="journal" id="sbref0062"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>X.P.</given-names></name><etal/></person-group><article-title>Economic burden of cancer in China during 1996-2014: a systematic review</article-title><source>Chinese J Oncol</source><volume>38</volume><issue>12</issue><year>2016</year><fpage>929</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.3760/cma.j.issn.0253-3766.2016.12.010</pub-id><pub-id pub-id-type="pmid">27998471</pub-id></element-citation></ref><ref id="bib0063"><label>63</label><element-citation publication-type="journal" id="sbref0063"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Analysis on the medical cost of inpatients with malignant tumors in Sichuan Province from 2015 to 2018</article-title><source>Chin Oncol</source><volume>29</volume><issue>10</issue><year>2020</year><fpage>758</fpage><lpage>762</lpage></element-citation></ref><ref id="bib0064"><label>64</label><element-citation publication-type="book" id="sbref0064"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name></person-group><part-title>Analysis of Hospitalization Expenses and its Influencing Factors of Breast Cancer Patients in Jilin Province</part-title><comment>Master's thesis</comment><year>2022</year><publisher-name>Jilin University</publisher-name></element-citation></ref><ref id="bib0065"><label>65</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name></person-group><article-title>Research of equity of primary health resources allocation in Inner Mongolia in 2016</article-title><source>Med Society</source><volume>32</volume><issue>03</issue><year>2019</year><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.13723/j.yxysh.2019.03.016</pub-id></element-citation></ref><ref id="bib0066"><label>66</label><element-citation publication-type="journal" id="sbref0066"><person-group person-group-type="author"><name name-style="western"><surname>Jing</surname><given-names>J.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name></person-group><article-title>Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China</article-title><source>Breast Cancer Res Treat</source><volume>181</volume><issue>2</issue><year>2020</year><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1007/s10549-020-05632-3</pub-id><pub-id pub-id-type="pmid">32306169</pub-id></element-citation></ref><ref id="bib0067"><label>67</label><element-citation publication-type="journal" id="sbref0067"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Z.</given-names></name></person-group><article-title>Medical economic burden in China: progress and prospects. Article in Chinese</article-title><source>Academic J Naval Med Uni</source><volume>39</volume><issue>10</issue><year>2018</year><fpage>1153</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.16781/j.0258-879x.2018.10.1153</pub-id></element-citation></ref><ref id="bib0068"><label>68</label><element-citation publication-type="journal" id="sbref0068"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Juan</given-names></name></person-group><article-title>Review of researches on economic burden of disease</article-title><source>Chin Health Econom</source><volume>26</volume><issue>11</issue><year>2007</year><fpage>72</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.3969/j.issn.1003-0743.2007.11.025</pub-id></element-citation></ref><ref id="bib0069"><label>69</label><element-citation publication-type="journal" id="sbref0069"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Prettner</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050</article-title><source>JAMA Oncol</source><volume>9</volume><issue>4</issue><year>2023</year><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1001/jamaoncol.2022.7826</pub-id><pub-id pub-id-type="pmid">36821107</pub-id><pub-id pub-id-type="pmcid">PMC9951101</pub-id></element-citation></ref><ref id="bib0070"><label>70</label><element-citation publication-type="book" id="sbref0070"><person-group person-group-type="author"><name name-style="western"><surname>Hai</surname><given-names>Q.</given-names></name></person-group><part-title>Research on Optimization of Medical and Health Resources Allocation in Inner Mongolia</part-title><comment>Master's thesis</comment><year>2022</year><publisher-name>Inner Mongolia Minzu University</publisher-name></element-citation></ref><ref id="bib0071"><label>71</label><element-citation publication-type="journal" id="sbref0071"><person-group person-group-type="author"><name name-style="western"><surname>Konishi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fujiogi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Michihata</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan</article-title><source>Breast Cancer Res Treat</source><volume>186</volume><issue>3</issue><year>2021</year><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1007/s10549-020-06069-4</pub-id><pub-id pub-id-type="pmid">33398479</pub-id></element-citation></ref><ref id="bib0072"><label>72</label><element-citation publication-type="journal" id="sbref0072"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Universal health insurance coverage and the economic burden of disease in Eastern China: a pooled cross-sectional analysis from the national health service survey in Jiangsu Province</article-title><source>Front Public Health</source><volume>10</volume><year>2022</year><object-id pub-id-type="publisher-id">738146</object-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.738146</pub-id><pub-id pub-id-type="pmcid">PMC8858842</pub-id><pub-id pub-id-type="pmid">35198521</pub-id></element-citation></ref><ref id="bib0073"><label>73</label><element-citation publication-type="journal" id="sbref0073"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Leng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>G.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Analysis on hospitalization expense of five kinds of cancers and its influencing factors</article-title><source>Chin Health Economics</source><volume>33</volume><issue>07</issue><year>2014</year><fpage>57</fpage><lpage>60</lpage></element-citation></ref><ref id="bib0074"><label>74</label><element-citation publication-type="book" id="sbref0074"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Q.</given-names></name></person-group><part-title>Study of Disease Burden on Malignant Tumor</part-title><comment>Master's thesis</comment><year>2009</year><publisher-name>Xiamen University</publisher-name></element-citation></ref><ref id="bib0075"><label>75</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Qadir</surname><given-names>H.</given-names></name><name name-style="western"><surname>Austin</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D.S.</given-names></name><etal/></person-group><article-title>A population-based study of cardiovascular mortality following early-stage breast cancer</article-title><source>JAMA Cardiol</source><volume>2</volume><issue>1</issue><year>2017</year><fpage>88</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2016.3841</pub-id><pub-id pub-id-type="pmid">27732702</pub-id></element-citation></ref><ref id="bib0076"><label>76</label><element-citation publication-type="journal" id="sbref0076"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>The evolution of ethnic integration patterns and their influencing factors in multi-ethnic cities from the perspective of residential space: a case study from Hohhot. Article in Chinese</article-title><source>Geographical Res</source><volume>37</volume><issue>02</issue><year>2018</year><fpage>333</fpage><lpage>352</lpage></element-citation></ref><ref id="bib0077"><label>77</label><element-citation publication-type="book" id="sbref0077"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>Y.</given-names></name></person-group><part-title>A Study on Ethnic Inter-Embedded Community in Wulat Front Banner, Inner Mongolia&#8211;Taking Wulashan Ethnic Community as An Example</part-title><comment>Master' thesis</comment><year>2023</year><publisher-name>Lanzhou University</publisher-name></element-citation></ref><ref id="bib0078"><label>78</label><element-citation publication-type="journal" id="sbref0078"><person-group person-group-type="author"><name name-style="western"><surname>Xian</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Study on the current situation of health resource allocation and the trend of equity in the Inner Mongolia Autonomous Region during the 12th five-year Plan period</article-title><source>Chin Health Resources</source><volume>21</volume><issue>01</issue><year>2018</year><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.13688/j.cnki.chr.2018.17545</pub-id></element-citation></ref><ref id="bib0079"><label>79</label><element-citation publication-type="book" id="sbref0079"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>L.</given-names></name></person-group><part-title>The study of the Inner Mongolia Autonomous Region society construction on the relationship between the Han Nationality and Mongolian</part-title><comment>Master's thesis</comment><year>2016</year><publisher-name>Tianjin University</publisher-name></element-citation></ref><ref id="bib0080"><label>80</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name name-style="western"><surname>Quincey</surname><given-names>K.</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>I.</given-names></name><name name-style="western"><surname>Winstanley</surname><given-names>S.</given-names></name></person-group><article-title>Marginalised malignancies': a qualitative synthesis of men's accounts of living with breast cancer</article-title><source>Soc Sci Med</source><volume>149</volume><year>2016</year><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2015.11.032</pub-id><pub-id pub-id-type="pmid">26689631</pub-id></element-citation></ref><ref id="bib0081"><label>81</label><element-citation publication-type="journal" id="sbref0081"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xian</surname><given-names>B.</given-names></name></person-group><article-title>Discharged patient direct disease burden analysis under different health insurance scheme in a top tertiary hospital in Inner Mongolia</article-title><source>Chin Hospitals</source><volume>21</volume><issue>08</issue><year>2017</year><fpage>56</fpage><lpage>58</lpage></element-citation></ref><ref id="bib0082"><label>82</label><element-citation publication-type="journal" id="sbref0082"><person-group person-group-type="author"><name name-style="western"><surname>Andrykowski</surname><given-names>M.A.</given-names></name></person-group><article-title>Physical and mental health status and health behaviors in male breast cancer survivors: a national, population-based, case-control study</article-title><source>Psychooncology</source><volume>21</volume><issue>9</issue><year>2011</year><fpage>927</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1002/pon.2001</pub-id><pub-id pub-id-type="pmid">21695746</pub-id></element-citation></ref><ref id="bib0083"><label>83</label><element-citation publication-type="journal" id="sbref0083"><person-group person-group-type="author"><name name-style="western"><surname>Amuguleng</surname><given-names>Sude.</given-names></name></person-group><article-title>Logical approach and the trend of the time of ethnic education policy of Inner Mongolia in the 70 years after the founding of New China</article-title><source>J Res Edu Ethni Minorities</source><volume>30</volume><issue>05</issue><year>2019</year><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.15946/j.cnki.1001-7178.2019.05.005</pub-id></element-citation></ref><ref id="bib0084"><label>84</label><element-citation publication-type="book" id="sbref0084"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name></person-group><part-title>Research on the Development of Mongolia Ethnic Education in Inner Mongolia Area</part-title><year>2013</year><publisher-name>Harbin Engineering University</publisher-name></element-citation></ref><ref id="bib0085"><label>85</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name name-style="western"><surname>Fentiman</surname><given-names>I.S.</given-names></name></person-group><article-title>Unmet needs of men with breast cancer</article-title><source>Europ J Surg Onco</source><volume>44</volume><issue>8</issue><year>2018</year><fpage>1123</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1016/j.ejso.2018.05.004</pub-id><pub-id pub-id-type="pmid">29801720</pub-id></element-citation></ref><ref id="bib0086"><label>86</label><element-citation publication-type="journal" id="sbref0086"><person-group person-group-type="author"><name name-style="western"><surname>Gaitanidis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alevizakos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pitiakoudis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wiggins</surname><given-names>D.</given-names></name></person-group><article-title>Trends in incidence and associated risk factors of suicide mortality among breast cancer patients</article-title><source>Psychooncology</source><volume>27</volume><issue>5</issue><year>2017</year><fpage>1450</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1002/pon.4570</pub-id><pub-id pub-id-type="pmid">29055289</pub-id></element-citation></ref><ref id="bib0087"><label>87</label><element-citation publication-type="journal" id="sbref0087"><person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Effects of marital status on breast cancer survival by age, race, and hormone receptor status: a population-based study</article-title><source>Cancer Med</source><volume>8</volume><issue>10</issue><year>2019</year><fpage>4906</fpage><lpage>4917</lpage><pub-id pub-id-type="doi">10.1002/cam4.2352</pub-id><pub-id pub-id-type="pmid">31267686</pub-id><pub-id pub-id-type="pmcid">PMC6712463</pub-id></element-citation></ref><ref id="bib0088"><label>88</label><element-citation publication-type="journal" id="sbref0088"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Using health insurance reimbursement data to identify incident cancer cases</article-title><source>J Clin Epidemiol</source><volume>114</volume><year>2019</year><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2019.06.009</pub-id><pub-id pub-id-type="pmid">31226412</pub-id></element-citation></ref><ref id="bib0089"><label>89</label><element-citation publication-type="journal" id="sbref0089"><person-group person-group-type="author"><name name-style="western"><surname>Sturgeon</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bluethmann</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>A population-based study of cardiovascular disease mortality risk in US cancer patients</article-title><source>Eur Heart J</source><volume>40</volume><issue>48</issue><year>2019</year><fpage>3889</fpage><lpage>3897</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehz766</pub-id><pub-id pub-id-type="pmid">31761945</pub-id><pub-id pub-id-type="pmcid">PMC6925383</pub-id></element-citation></ref></ref-list><sec id="sec0018" sec-type="supplementary-material"><label>Appendix</label><title>Supplementary materials</title><p id="para0030a">
<supplementary-material content-type="local-data" id="ecom0001" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.pdf" position="float" orientation="portrait"><alt-text>Image, application 1</alt-text></media></supplementary-material>
</p></sec><ack id="ack0001"><sec id="sec0014"><title>Ethics statement</title><p id="para0032">This study was approved by the Medical Ethics Committee of the Inner Mongolia Center for Disease Control and Prevention (approval number: NMCDCIRB2021001). Informed consent from participants was exempted due to the retrospective nature of this study.</p></sec><sec id="sec0016"><title>Acknowledgements</title><p id="para0034">This work was supported by the <funding-source id="gs0001"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>Natural Science Foundation of China</institution></institution-wrap></funding-source> (grant numbers: <award-id award-type="grant" rid="gs0001">82173616</award-id>, <award-id award-type="grant" rid="gs0001">72342015</award-id>).</p></sec><sec id="sec0015"><title>Author contributions</title><p id="para0033">C.J.Y., Q.L.Y., Y.Y., Q.M., Z.Y.J., X.Y.F., and W.S.F. led the conceptual design of the study; C.J.Y., Q.L.Y., Y.Y., Z.Y.J., and W.S.F. participated in drafting the manuscript; C.J.Y., Z.Y.J., K.W.W., Z.H.Z.W., Y.Y.L., K.Y.L., J.Y.L., R.Y.T., X.L., H.G.H., R.J., Y.X., D.S.W., Y.X.Y., S.Y.T., Y.Y.Z., W.Q.R., H.J., W.Y.W., L.G.Z., W.M.Y., Z.X.Y, and W.S.F. participated in the data preprocessing and statistical analysis; X.Y.F. and W.S.F. offered administrative, technical, and material support; X.Y.F. and W.S.F. supervised the whole course of the study. All authors contributed in data interpretation and critical revision of manuscript for important intellectual content.</p></sec></ack><fn-group><fn id="sec0017" fn-type="supplementary-material"><p id="para0006a">Supplementary material associated with this article can be found, in the online version, at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jncc.2025.05.006" id="interref0001">doi:10.1016/j.jncc.2025.05.006</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>